The QualityStocks Daily Monday, July 8th, 2019

Today's Top 3 Investment Newsletters

HotOTC (GTVI) +217.14%

StockMarketWatch (NAKD) +73.68%

MarketClub Analysis (SOLY) +61.85%

The QualityStocks Daily Stock List

Windtree Therapeutics, Inc. (WINT)

AI StockFinder, OTC Markets, Insider Financial, Wallet Investor, Marketbeat, Investors Hangout, InvestorsHub, Insider Tracking, PR Newswire, Zacks, Super Stock Screener, Investing Note, Modest Money, Investors Village, Simply Wall St, MacroTrends, Infront Analytics, Clay Trader, Barchart, Market Screener, Biz Journals, Annual Reports, and Stockhouse reported earlier on Windtree Therapeutics, Inc. (WINT), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

Windtree Therapeutics, Inc. is a clinical-stage, biopharmaceutical and medical device company based in Warrington, Pennsylvania. The Company concentrates on the development of novel therapeutics intended to address significant unmet medical needs in important acute care markets. Windtree has four programs in clinical development and manifold pre-clinical programs that encompass respiratory and cardiovascular disease states. Windtree Therapeutics lists on the OTC Markets Group’s OTCQB.

Three of Windtree’s clinical programs are in late-stage development. They include AEROSURF®, an inventive combination drug/device product candidate designed to deliver the Company’s proprietary synthetic, peptide-containing surfactant non-invasively to premature infants with respiratory distress syndrome (RDS). Aerosol Delivery System (ADS) is the technology used in the medical device component of Windtree's AEROSURF® combination drug/device product candidate.

In addition, Windtree has its istaroxime, a novel, dual-acting agent undergoing development to improve cardiac function in patients with acute heart failure while avoiding the unwanted side effects of existing treatments. Furthermore, the Company has its rostafuroxin, a novel precision drug product undergoing development to target hypertensive patients with certain genetic profiles in the important group of patients with resistant hypertension. Windtree Therapeutics also has numerous pre-clinical products. This includes potential heart failure therapies delivered orally, which are based on SERCA2a mechanism of action.

In early June, Windtree Therapeutics and Eleison Pharmaceuticals LLC jointly announced positive results of the feasibility study using Windtree's proprietary Aerosol Delivery System (ADS) aerosolization technology to deliver Eleison's inhaled lipid cisplatin (ILC). Eleison Pharmaceuticals’ is a specialty pharmaceutical company developing life-saving therapeutics for rare cancers.

Windtree Therapeutics has licensed and further developed its ADS using unique aerosolization technology to deliver pulmonary surfactants (alone or in combination with any other pharmaceutical compound(s)) as an active ingredient for the prevention or treatment of respiratory indications. The ADS has been shown to deliver high aerosol output rates, small and uniform particle size, and consistent aerosol characteristics throughout extended dosing periods. This includes particularly difficult to aerosolize substances like lipids.

Mr. Craig Fraser, Windtree Therapeutics’ Chief Executive Officer, said, "We are very encouraged by this research collaboration to date, which has demonstrated the drug delivery potential of our device technology beyond treating premature infants with RDS. The ADS is an innovative platform that we plan to continue to study in our AEROSURF development program and potentially in additional acute care drug delivery uses, starting with this important area of oncology and Eleison's unique product candidate ILC.”

Windtree Therapeutics, Inc. (WINT), closed Monday's trading session at $4.60, even for the day, on 1 volume with 1 trade. The average volume for the last 3 months is 417 and the stock's 52-week low/high is $2.04999995/$5.3499999.

chart

Harvest Health & Recreation, Inc. (HRVSF)

Midas Letter, Cannabis Stock Trades, Proactive Investors, InvestorsHub, Cannabis Business Times, Micro Cap Daily, New Cannabis Ventures, Profit Confidential, Market Watch, and Stockhouse reported earlier on Harvest Health & Recreation, Inc. (HRVSF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

A vertically-integrated cannabis enterprise, Harvest Health & Recreation, Inc. has one of the largest and deepest footprints in the U.S. The Company is a multi-state cannabis operator (MSO). Its mission is to improve lives through the goodness of cannabis. Harvest Health & Recreation is focused on its vision to become the most valuable cannabis company worldwide. The Company is headquartered in Tempe, Arizona and lists on the OTC Markets Group’s OTCQX.

Harvest Health & Recreation’s total vertical solution includes industry-leading cultivation, manufacturing, and retail facilities, construction, real estate, technology and operational expertise -leveraging in-house legal, HR (Human Resources) and marketing teams, along with proven experts in writing and winning State-based applications. Since 2011, the Company’s commitment has been to aggressively expanding its Harvest House of Cannabis retail and wholesale presence across the U.S., acquiring, creating and growing foremost brands for patients and consumers nationally, and continuing on a course of profitable growth.

Subject to the completion of announced acquisitions, Harvest Health & Recreation will have the largest footprint in the U.S., with rights to 219 facilities, of which 142 are retail locations and more than 1,580 employees across 17 States. It currently operates or has rights to operate in cannabis facilities or expects to have rights to acquire licenses following the closings of recently announced acquisitions in Arizona, Arkansas, California, Delaware, Florida, Illinois, Maryland, Massachusetts, Michigan, New Jersey, Nevada, North Dakota, Ohio, Oklahoma, Pennsylvania and Puerto Rico.

Harvest Health & Recreation has entered into a binding, definitive agreement to acquire CannaPharmacy, Inc., subject to satisfaction of customary closing conditions. This includes receipt of regulatory approvals in the relevant States. CannaPharmacy owns or operates (via management companies) cannabis licenses in Pennsylvania, Delaware, New Jersey, and Maryland. It also holds a minority interest in a pending licensee in Colombia.

Harvest Health & Recreation said today it is acquiring the only licensed cannabis dispensary in the State of Arizona. It is acquiring Leaf Life in a deal that includes the dispensary located in Casa Grande. "Arizona is the third largest medicinal cannabis market in the United States, yet too many in our communities still do not have adequate access to dispensaries that offer the high-quality medicinal products and expert staff required to improve patient education and treatment outcomes," said Harvest Health & Recreation Executive Chairman, Mr. Jason Vedadi.

Harvest Health & Recreation, Inc. (HRVSF), closed Monday's trading session at $5.9531, off by 1.177%, on 247,846 volume with 587 trades. The average volume for the last 3 months is 344,109 and the stock's 52-week low/high is $0.075000002/$10.8510999.

chart

Cardiol Therapeutics, Inc. (CRTPF)

NIC Investors, Investorx, Stock Target Advisor, Invest Tribune, Growstox, Market Screener, Investing News, Stock Gumshoe, OTC Markets, Cannabis FN, and Stockhouse reported previously on Cardiol Therapeutics, Inc. (CRTPF), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Cardiol Therapeutics, Inc. specializes in the research and commercial development of novel drug therapies using proprietary drug-delivery systems. It is a leader in the research and commercial development of pharmaceutical CBD and targeted therapies for inflammatory diseases. Cardiol is taking advantage of its expertise in pharmaceutical CBD to develop ultra-pure CBD products for commercialization in the billion dollar market for medicinal cannabinoids in Canada. A biotech company, Cardiol Therapeutics is based in Oakville, Ontario.

The Company’s nanotherapeutics are founded on a patented family of biocompatible and biodegradable amphiphilic block co-polymers made from polyethylene glycol (PEG) and polycaprolactone (PCL). PEG and PCL have a long history of safe use in humans. Cardiol’s proprietary nanoparticles have improved inherent stability and biocompatibility. They can also be customized to optimize the encapsulation and release characteristics of a broad array of pharmaceuticals.

Cardiol has a view to expanding into Latin America and Europe, and to utilizing nanotechnologies designed to deliver cannabinoids and other anti-inflammatory drugs for the treatment of heart failure. The Company is leveraging its expertise in pharmaceutical cannabinoids to develop proprietary formulations for commercial development in three important medical markets.

These include commercializing a line of pharmaceutically-manufactured pure cannabidiol products in the developing market for medical cannabinoids, developing nanotechnologies designed to deliver cannabinoids and other anti-inflammatory drugs for the treatment of heart failure; and pursuing an immunotherapeutics program beginning with an innovative cancer immunotherapeutic in combination with cannabinoids for Glioblastoma Multiforme, a Fast Track eligible orphan indication.

The design of Cardiol Therapeutics’ proprietary nanotherapeutics are to increase the compatibility of drugs with the aqueous blood circulation, improve pharmacokinetics, and facilitate drug accumulation in the failing heart. Additionally, Cardiol is commercializing a line of pharmaceutically-manufactured pure cannabidiol products to address the growing market for medical cannabinoids. In collaboration with Dalton Pharma Services, the Company is developing unique manufacturing expertise in the production of pharmaceutical cannabinoids in support of its nanotherapeutics program in heart failure.

In June, Cardiol Therapeutics announced it is planning a global clinical trial in acute myocarditis utilizing its CardiolRx CBD formulation. CardiolRx is the Company’s pure pharmaceutically-produced CBD. CardiolRx is cGMP certified; it does not contain any THC (Tetrahydrocannabinol). Cardiol plans to commercialize CardiolRx pharmaceutical CBD during 2019 in the billion-dollar market for medicinal cannabinoids in Canada. The Company is pursuing market introduction opportunities in Europe and Latin America.

Cardiol Therapeutics, Inc. (CRTPF), closed Monday's trading session at $3.2862, off by 6.0895%, on 15,564 volume with 39 trades. The average volume for the last 3 months is 31,640 and the stock's 52-week low/high is $2.51999998/$10.00.

chart

China Health Industries Holdings, Inc. (CHHE)

The Hot Penny Stocks, Hot OTC Stocks, Wallmine, InvestorsHub, Marketwired, Proactive Investors, OTC Markets, Simply Wall St, Stockhouse, Stock Earnings, Zacks, Wallet Investor, YCharts, GuruFocus, and Market Screener reported beforehand on China Health Industries Holdings, Inc. (CHHE), and today we report on the Company, here at the QualityStocks Daily Newsletter.

China Health Industries Holdings, Inc. is a holding company vertically integrated with the operations in its subsidiaries in the People's Republic of China. It specializes in research and development (R&D), production, marketing and distribution of hemp derivative products, medicines and health supplement products. China Health Industries Holdings is based in Harbin, China. The Company lists on the OTC Markets’ OTCQB.

China Health Industries owns GMP certified plants and facilities. It manufactures 21 CFDA approved medicines and 14 health supplement products covering five kinds of dosage forms. These include soft capsule, hard capsule, tablet, granule, and oral liquid. The Company’s product series encompass hemp derivative foods, hemp derivative medicines, externally used medicines and health foods. These products address important major markets such as women’s products, geriatric products, children’s products, as well as other important market sectors.

China Health Industries’ intention is to market much of its product line covering all of China and also overseas countries. As a first step toward implementing its business plan, the Company strategically transferred its business to production, sales and R&D of Hemp-based products in 2018. It is working to establish sales centers and chain-stores to connect consumers closely with its products.

China Health Industries announced this past December that it completed the strategic transformation from being a traditional health supplement products manufacturer to a hemp derivative products pioneer. Since May 2018, the Company’s hemp derivative products have been launched into the Chinese marketplace. This includes Hemp Oil, Hemp Protein Powder, Hemp Polypeptide and Hemp Cosmetics.

This past May, China Health Industries Holdings announced financial results for its Q3 ended March 31, 2019. Total Revenues grew by $664,269 or 43.18 percent for the three months ended March 31, 2019, versus the same period the year prior. Gross Margin rose by $1,137,102 or 203.41 percent for the three months ended March 31, 2019 versus the same period in 2018. Net Income was $767,929 for the three months ended March 31, 2019, versus Net Income of $10,711 for the three months ended March 31, 2018.

China Health Industries Holdings, Inc. (CHHE), closed Monday's trading session at $0.75, even for the day. The average volume for the last 3 months is 1,327 and the stock's 52-week low/high is $0.301999986/$1.75.

chart

CleanSpark, Inc. (CLSK)

Wallet Investor, Stockwatch, Barchart, Trading View, Uptick Newswire, Insider Financial, Micro Cap Daily, Financial Buzz, Marketbeat, Equities, GlobeNewswire, Pot Stock News, Insider Tracking, PR Newswire, Market Screener, Stockhouse, Simply Wall St, YCharts, InvestorsHub, and Dividend Investor reported earlier on CleanSpark, Inc. (CLSK), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

CleanSpark, Inc. is a microgrid business with advanced engineering, software and controls for innovative distributed energy resource (DER) and microgrid deployments. The OTCQB-listed Company provides advanced energy software and control technology that enables a plug-and-play enterprise solution to modern energy challenges. CleanSpark's customers include energy consumers and the distributed energy ecosystem at large: developers, installers, EPCs, IPPs, and energy storage vendors. The Company formerly went by the name Stratean, Inc. It changed its corporate name to CleanSpark, Inc. in November 2016. CleanSpark has its head office in Utah.

CleanSpark’s services consist of intelligent energy monitoring and controls, microgrid design and engineering, microgrid consulting services, and turn-key microgrid implementation services. Its software enables energy users to attain resiliency and economic optimization. The Company’s software is uniquely capable of enabling a microgrid to be scaled to the user's specific needs. It can be broadly implemented across commercial, industrial, military, agricultural and municipal, deployment.

CleanSpark’s Microgrid Value Stream Optimizer outputs are a client’s customized guide to maximizing their energy project’s ROI (Return on Investment). State-of-the-art data analytics account for real costs, precise utility rate models, equipment performance, and actual energy consumption. They outline what type of energy resources are to be built, what it will cost, and how it will perform upon deployment.

CleanSpark’s mPulse software is an innovation in controls capable of integrating manifold Distributed Energy Resources (DER). This includes storage, renewables, as well as fossil fuel technologies. The Company’s intelligent software package collects, archives and analyzes data 24/7 providing real-time control and reporting. Pertaining to Engineering & Grid Development Services, CleanSpark’s mVSO provides critical information. It is also the starting point for the Company’s microgrid development services.

Recently, CleanSpark announced record equipment sales and shipments for the month of May. Equipment sales for May were greater than $1 million, versus equipment sales of $431,000 during the first three months of 2019. In total, equipment sales for the quarter ending June 30, 2019 are projected to surpass $1.5 million. Equipment sales for the Company’s fiscal year are on course to surpass prior estimates of $4 million.

Additionally, CleanSpark's contracted back log for equipment increased to $6.1 million. This represents an increase of more than $2 million since March 31, 2019.

CleanSpark, Inc. (CLSK), closed Monday's trading session at $1.79, off by 5.7895%, on 72,691 volume with 81 trades. The average volume for the last 3 months is 108,690 and the stock's 52-week low/high is $1.10000002/$15.0100002.

chart

Gran Colombia Gold Corp. (TPRFF)

GlobeNewswire, Micro Small Cap, Mining & Energy, MarketWatch, Junior Mining Network, Metals News, GuruFocus, Gold Stock Data, Wallet Investor, The Prospector News, and Resource World reported previously on Gran Colombia Gold Corp. (TPRFF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Gran Colombia Gold Corp. is a mid-tier gold producer headquartered in Toronto, Ontario. The Company’s primary emphasis is in Colombia where it is presently the largest underground gold and silver producer with a number of mines in operation at its Segovia and Marmato Operations. Gran Colombia is now in the midst of an expansion and modernization project at its high grade, production stage Segovia Operations. Gran Colombia Gold’s shares trade on the OTC Markets Group’s OTCQX.

The Company’s focus is on the development of the Segovia Operations and Marmato projects to generate robust cash flows in the short, medium and long term. Gran Colombia Gold produces gold from the Segovia Operations, an area of about 9,000 hectares in the Segovia-Remedios mining district of Antioquia. The Segovia Operations include the El Silencio, Providencia and Sandra K underground mines in the Municipality of Segovia, and the Carla underground mine in the Municipality of Remedios, located approximately 10 km southeast of the Segovia mines.

The Marmato Project contains total estimated resources of around 8 million ounces of gold and close to 38 million ounces of silver situated in the Caldas department in the core of the Middle Cauca gold district. The Marmato Project has first-class infrastructure, being located by the Pan American Highway with access to Medellin to the north and Manizales to the south. It has access to the national electricity grid that runs near the property.

Additionally, Gran Colombia Gold has its Zancudo project. The Zancudo project is in the Titiribí mining district of Antioquia. It comprises an historical gold mine, the Independencia Mine, in the Middle Cauca Gold Belt that produced roughly 130,000 ounces of gold with recovered grades of 14.6 g/t Au and 108.4 g/t Ag.

Gran Colombia Gold has increased its equity position in Sandspring Resources Ltd. (TSX-V: SSP, OTCQX: SSPXF) to 19.96 percent via a non-brokered private placement completed June 12, 2019 by Sandspring. Sandspring Resources’ intention is to use the proceeds of the Private Placement to continue work on the re-scoping of the Toroparu Project, additional exploration at its Chicharron Project, and also for general working capital. On June 4, 2019, Sandspring announced positive results of a preliminary economic assessment (PEA) for its Toroparu Project. The next stage of development will encompass completion of a feasibility study (FS) for the project.

Recently, Gran Colombia Gold announced that it produced a total of 18,528 ounces of gold in May 2019. This brings the total for the first five months of 2019 to 99,601 ounces. This is up 14 percent over the first five months of 2018. The Company’s trailing 12 months’ total gold production at the end of May 2019 of 230,136 ounces is up nearly 6 percent over 2018’s annual production. It remains above the top end of Gran Colombia’s guidance range for 2019 of between 210,000 and 225,000 ounces.

Gran Colombia Gold Corp. (TPRFF), closed Monday's trading session at $3.12, off by 1.2658%, on 7,676 volume with 14 trades. The average volume for the last 3 months is 22,701 and the stock's 52-week low/high is $1.56630003/$3.54859995.

chart

Kona Gold Solutions, Inc. (KGKG)

Clay Trader, Dividend Investor, InvestorsHub, Wallet Investor, Micro Cap Daily, Talkmarkets, Trading View, Market Screener, 4-Traders, Discovery Stocks, Insider Financial, Stockwatch, Stockhouse, and Wallmine reported previously on Kona Gold Solutions, Inc. (KGKG), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Kona Gold Solutions, Inc. is a hemp and CBD lifestyle brand centered on product development in the functional beverage sector. The Company has created wholly-owned subsidiaries, Kona Gold LLC, HighDrate, LLC, and Gold Leaf Distribution, LLC. Kona Gold Solutions has its corporate headquarters in Melbourne, Florida. The Company’s shares trade on the OTC Markets.

Subsidiary Kona Gold, LLC has developed a premium Hemp Infused Energy Drink line. The HighDrate, LLC subsidiary has developed the beverage industry’s first CBD Energy Water, available in four flavors. The Gold Leaf Distribution, LLC subsidiary was established to fill Kona Gold Solutions’ distribution needs in markets it wants to quickly enter.

Kona Gold Solutions announced this past spring that it commenced production of its new Hemp Energy Drink and CBD Energy Water flavors. Its Kona Gold Hemp Energy Drink line extension includes Bubble Gum and Candy Apple flavors. The line extension for its HighDrate CBD Energy Waters includes Blue Island Punch and Sour Apple.

Kona Gold Solutions has launched its above-mentioned Bubble Gum and Candy Apple flavored hemp energy drinks. The announcement is coming off the success of the Company’s new Cotton Candy and Cherry Vanilla flavors that went to market in late 2018 and continue to be Kona Gold’s top selling hemp energy drinks.

Recently, Kona Gold Solutions partnered with 16 new distributors. The new distribution partners are in California, Idaho, Indiana, Kentucky, Louisiana, Minnesota, Nevada, New Mexico, New York, Oklahoma, Texas, Virginia, Washington, and Wisconsin. At present, the Company has distribution partners in 24 States.

Kona Gold Solutions recently signed an LOI (Letter of Intent) to lease warehouse space in Greer, South Carolina, just outside of Greenville. This warehouse encompasses 30,000 square feet, in which Kona Gold will acquire 15,000 square feet with the option to lease the additional 15,000 square feet within two years.

The new warehouse space will operate as the Company’s distribution hub, where all product will be stored and shipped to distributors throughout the nation. Furthermore, this location will serve as a new Gold Leaf Distribution hub as Kona Gold expands Gold Leaf’s distribution presence in new markets.

Last week, Kona Gold Solutions announced it beat Q2 protected revenue of $400,000 by more than $320,000. The Company had its first ever profitable quarter on revenue of greater than $720,000 from sales of its popular Kona Gold Hemp Energy Drinks and HighDrate CBD Energy Waters. Kona Gold will exceed $1 million in revenue for 2019 in July.

Kona Gold Solutions’ two product lines, Kona Gold and HighDrate, can now be purchased in 31 States in popular convenience stores, grocery stores, and specialty stores. Product re-orders from distributors are at its highest pace as demand for its products strengthens.

Kona Gold Solutions, Inc. (KGKG), closed Monday's trading session at $0.123888, off by 0.929228%, on 5,054,381 volume with 425 trades. The average volume for the last 3 months is 5,860,397 and the stock's 52-week low/high is $0.007199999/$0.149399995.

chart

Prize Mining Corporation (PRZFF)

Investing News, The Street, Junior Mining Network, Science of Stocks, Small Cap Power, Stockhouse, Stock Market Watch, Market News Updates, Barchart, Wallet Investor, 4-Traders, OTC Markets, Business Insider, Trading View, and Penny Stock Hub reported previously on Prize Mining Corporation (PRZFF), and we also report on the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Prize Mining Corporation explores for and develops mineral properties. The Company’s flagship project is the Manto Negro Copper Project (Coahuila, Mexico). Additionally, it has its Kena & Daylight Gold project. An exploration stage company, Prize Mining is based in Calgary, Alberta.

The Manto Negro Copper Project has sedimentary stratabound oxidized and reduced “Red Bed type” copper deposits. The Manto Negro property consists of 17,659 hectares. It includes more than 35 known occurrences of copper mineralization.

Prize Mining received the NI 43-101 Technical Report for the Manto Negro property in Coahuila, Mexico from geological consultants, Norwest Corporation of Calgary, Alberta. The Technical Report includes a review of the regional and local geology, mineralization types and grades, exploration history and results, overall mineral potential and recommendations for more work. The report does not include any estimate of mineral resources nor reserves.

The Kena & Daylight Gold project is a large property with first-rate infrastructure. This Property comprises 9,000 hectares in southeastern British Columbia. The Property is 10 kilometers from the Town of Nelson. The Gold Mountain Zone and Kena Gold Zone are a porphyry gold deposit with high grade zones.

The Kena Property has an NI 43-101 resource of an indicated 481,000 ounces of gold and an inferred 1,318,000 ounces of gold. The Daylight claims have four historical producing mines with grades as high as 37 g/t gold. The Company’s focus on the Daylight Property is on four large gold-bearing targets. 

Prize Mining announced this past December that step-out diamond drill holes at the Pilar Grande area of the Manto Negro Copper Project continues to intersect copper-silver mineralization. Drilling at the El Granizo site encountered complex faulting that is yet to be completely interpreted as to the impact on mineralization.

Also in December, the Company reported results from the Phase I and II diamond drill programs from the Kena Gold Project, positioned in the highly prospective Kootenay Boundary area near Nelson, British Columbia. The focus of the exploration program at the Kena Gold Project has been on the Toughnut Property. Drilling on Toughnut has intersected significant near surface gold mineralization. The higher grade intercepts demonstrate the potential for a much larger gold system on Prize Mining’s property.   

Recently, Prize Mining provided an update on the results and success of its Phase 1 diamond drilling program at the Manto Negro Copper Project.

Mr. Michael McPhie, Prize Mining’s President and Chief Executive Officer, said, "We are very pleased to announce the completion of and results from our Phase 1 exploration drilling program at the Manto Negro Copper Project. We have tested just a small part of our 18,000 hectare property that contains some 35 surface copper showings over a 40 kilometer trend. These results provide us with confidence in the scale, grade and potential of this district size property and will guide our focus in the Phase 2 program that will begin in the weeks ahead."

Prize Mining Corporation (PRZFF), closed Monday's trading session at $0.0209, up 57.1429%, on 12,500 volume with 2 trades. The average volume for the last 3 months is 12,957 and the stock's 52-week low/high is $0.012684999/$0.154699996.

chart

CurAegis Technologies, Inc. (CRGS)

Penny Stock Tweets, Dividend Investor, Insider Mole, Equity Clock, Market Screener, Morningstar, MarketWatch, 4-Traders, InvestorsHub, Stockwatch, Investor Place, Simply Wall St, Marketbeat, Capital Cube, YCharts, Stock Invest, Barchart, The Street, OTC Markets, Infront Analytics, Stockhouse, last10k, Wallet Investor, and TradingView reported earlier on CurAegis Technologies, Inc. (CRGS), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter. 

Technologies, Inc. develops and markets advanced technologies in the areas of power, safety, and wellness. The Company consists of two independent divisions. One is its CURA Division and the other is its Aegis Division.  CurAegis is now concentrating on commercialization strategies in diverse technologies. These include the CURA system, which includes the myCadian™ watch that measures degradation of alertness and sleep attributes; the Z-Coach e-learning education and training tool, and the Aegis hydraulic pump. OTCQB-listed, CurAegis Technologies is based in Rochester, New York.

The CURA™ system and the myCadian™ watch enable the user and third parties to anticipate and prevent undesired or disastrous situations caused by the degradation of alertness. CurAegis completed its validation studies of the CURA System at the University of Colorado at Boulder and the University of Rochester Medical Center. The Company previously said that it can now state that it can predict a person’s fatigue level, at close to laboratory accuracy, in real-time.

The CURA System consists of hardware and software, which measures numerous metrics to establish that a person's ability to perform a task or job appears to be degrading. The CURA division is developing a proprietary technology and family of products designed to measure the reduction in a person’s alertness and to train persons on how to improve alertness levels. The CURA System gives a person accurate and relevant real-time information regarding their current and long-term sleep and fatigue health.

The Company’s Aegis hydraulic pump (Aegis Division) is an innovative hydraulic design. Its goal is to deliver better efficiencies in a package that is smaller and lighter than contemporary technologies.  Moreover, in 2015, the Z-Coach e-learning tool was acquired by CurAegis Technologies. The Z-Coach® Wellness Program is a robust, proven and proprietary online sleep training and education solution to address sleep issues and improve wellness.

In December, Mr. Richard A. Kaplan, Chief Executive Officer of CurAegis Technologies announced that Mr. Lance F. Drummond was appointed to the Company’s Board of Directors. At present, Mr. Drummond is a Board member of Federal Home Loan Mortgage Corporation (Freddie Mac). He has served on the Audit Committee and Nominations and Governance Committee since 2015.  He is a Board member for United Community Bank, Inc. since 2018, where he serves on the Risk Committee, Nominating and Governance Committee and Compensation Committee.

CurAegis Technologies, Inc. (CRGS), closed Monday's trading session at $0.13, up 30.00%, on 15,000 volume with 5 trades. The average volume for the last 3 months is 17,339 and the stock's 52-week low/high is $0.100000001/$0.490000009.

chart

Select Sands Corp. (SLSDF)

Investors Hangout, Wallet Investors, Penny Stock Hub, Wall Street Analyzer, Investopedia, Stock Gumshoe, Amigo Bulls, Tip Ranks, YCharts, Marketbeat, The Street, InvestorsHub, Stockhouse, TradingView, Zacks, Penny Stock Tweets, MarketWatch, Simply Wall St, Marketwired, Barchart, and OTC Markets reported on Select Sands Corp. (SLSDF),  and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Select Sands Corp. is an industrial Silica Product company listed on the OTCQX. The Company is developing its 100 percent owned, 520-acre Northern White, Tier-1, silica sands project located in the State of Arkansas. The Company previously went by the name La Ronge Gold Corp. It changed its name to Select Sands Corp. in November of 2014. The Company has its corporate office in Vancouver, British Columbia.

Silica Sand is quartz that over time, through the work of water and wind, has been broken down into tiny granules. Commercial Silica Sand is extensively used as a proppant by oil and gas companies. Furthermore, it is used in industrial processing. Whole Grain and Ground Silica products range in size, distributions, grain shapes, as well as chemical purity.

The Company’s Sandtown project has NI 43-101 (National Instrument 43-101) compliant Indicated Mineral Resources of 42.0MM tons (TetraTech Report; February 2016). Bell Farm has Inferred Mineral Resources of 49.6MM tons (Kleinfelder Report; April 2017). Both deposits are considered Northern White finer-grade sand deposits of 40-70 Mesh and 100 Mesh.

Select Sands has its Ozark Operations in Arkansas. This property is underlain by the Ordovician St. Peter sandstone formation, the source of premier industrial silica sand ‘Ottawa White’ frac sand. The Company entered into a binding Letter of Agreement for an option to acquire a 100 percent undivided right, title, and interest in the roughly 520-acre premium grade industrial silica sand/frac sand project in northeast Arkansas. The Arkansas project is strategically situated to supply sand to major U.S. oil & gas and Industrial & Specialty markets.

On October 18, 2018, Select Sands announced it placed certain employees at its Arkansas operations on temporary furlough until further notice.  Shipments and limited production continue. The Company is pursuing additional opportunities. This includes evaluating sand production and sand-related business opportunities in or near other basins.

Recently, Select Sands announced that it sold 80,000 tons of frac and industrial sands during Q3 2018. This is within its previous guidance of between 65,000 to 95,000 tons.

Zig Vitols, President and Chief Executive Officer of Select Sands, stated, “Sales continue through the quarter and are being supported with appropriate production. Much of the operations are running on single shift to insure optimum control of overhead.  As a result, the company has maintained its cash position similar to that reported at the end of Q2.  We believe the mid to long-term outlook for demand fundamentals will see a return of stronger shipments of the company’s products.”

Select Sands Corp. (SLSDF), closed Monday's trading session at $0.05, up 10.2536%, on 115,000 volume with 9 trades. The average volume for the last 3 months is 22,748 and the stock's 52-week low/high is $0.039099998/$0.38499999.

chart

Blow & Drive Interlock Corp. (BDIC)

MarketWatch, YCharts, TradingView, Equities.com, and News to Watch reported on Blow & Drive Interlock Corp. (BDIC),  and we report on the Company as well, here at the QualityStocks Daily Newsletter.

Blow & Drive Interlock Corp. provides automotive and criminal offender monitoring security products. The Company has its state-of-the-art ignition interlock device, the BDI-747. The device is approved and available in eight states for evidentiary and preliminary screening use. In essence, Blow & Drive Interlock is an offender monitoring and police-grade alcohol detection device manufacturing and offender monitoring business.  Blow & Drive Interlock is based in Los Angeles, California. 

Interlocks are required for use by DUI or DWI (Driving Under The Influence or Driving While Intoxicated) offenders. This is as part of their mandatory court or motor vehicle department program. The Company’s aim  is to have the BDI-747 available to customers across the U.S.

In addition, Blow & Drive Interlock continues to do research and development (R&D) on the next stage of offender monitoring. The Company believes this will be Smartphone enabled monitoring applications, which could reduce or eliminate  the requirement for ankle bracelets or hand-held breathalyzers.  

The BDI-747 is an ignition interlock device, breath-alcohol testing device about the size of a Smartphone. The ignition interlock device requires the driver to exhale into the device prior to starting the vehicle. The device will prevent the vehicle from starting if the driver's blood-alcohol content exceeds a predetermined set level. 

The BDI-747 can record BAC levels. It provides 2-way communication, GPS location technology, and image technology. Moreover,  the BDI-747 is wireless. 

One of Blow & Drive Interlock’s new products is its Home Alcohol Monitoring Device.  This handheld device has a camera and GPS/WIFI & live streaming. It enables those in Judicial and Probation departments to monitor offenders who are required to stay sober from alcohol while on probation. 

The Company also has its 4G LTE Live-Streaming Video Body Worn Camera for Law Enforcement.  With the 4G LTE Live-Streaming Video Body Worn Camera, Law Enforcement Personnel on the scene can transmit a live feed from their body cameras to headquarters. This allows police decision makers’ access to real time information regarding what each officer is seeing. 

The body camera weighs roughly 210g. It provides up to 32 GB of memory and 5-megapixel recording. In February, Blow & Drive Interlock introduced BADGECAM. This is a body worn camera akin to the models law enforcement officers use but to protect anyone at anytime. The BADGECAM can be heavily incorporated by Human Resources (HR) departments, security personnel, counter staff, or any other jobs that come with a potential confrontation.

The intention of BADGECAM is to become a vital preventative measure against workplace violence, discrimination, or personal/sexual harassment. With BADGECAM, one can immediately begin recording up to 6 hours of high quality video and audio with a single pull.

The design of BADGECAM is to be affixed to any article of clothing. Blow & Drive Interlock plans to launch the BADGECAM between Q2 and Q3 of 2018.

Blow & Drive Interlock Corp. (BDIC), closed Monday's trading session at $0.097, up 49.2308%, on 101 volume with 1 trade. The average volume for the last 3 months is 1,644 and the stock's 52-week low/high is $0.050099998/$0.219899997.

chart

Tautachrome, Inc. (TTCM)

MarketWatch and InvestorsHub reported on Tautachrome, Inc. (TTCM), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Tautachrome, Inc. is an emerging growth enterprise in the developing digital imagery technology sector. It is a developer of software applications for trustable and engageable digital pictures and videos. The Company’s chief priority is developing its branded KlickZie platform. An Internet technology development business, Tautachrome is headquartered in Oro Valley, Arizona and has operations in the United States and Australia. 

The KlickZie platform will turn smartphones into trusted imagers. This means the pictures and videos they capture can be verified as original, untampered,  and un-photoshopped. Additionally, the KlickZie platform creates imagery that is interactive and engageable. 

The KlickZie platform will serve as the world’s first imagery-based social website network. Through clicking or tapping on a KlickZie'd image, users can communicate with the image's author or others presently looking at the image, in an engaging way. 

Basically,  KlickZie is an image verification service for smartphones. It brings trust back to digital imagery. In addition, KlickZie turns the smartphone into a reliable image source. Smartphone users download KlickZie’s free software to take their pictures and videos. 

KlickZie pictures and videos are invisibly marked, stored in the KlickZie cloud, and guaranteed free from manipulation. The cloud will certify the authenticity of any KlickZie picture or video.

Tautachrome also has pioneering patents pending. These include Talk-to-the-Picture social networking and the abovementioned trustable imagery-based interaction. 

Tautachrome is establishing a development team of providers to develop a blockchain based cryptocurrency ecosystem with a cryptotoken designated “KLK”. It will be the currency of the KlickZie community internationally.

This will permit KlickZie users to monetize their pictures and videos. As a result, it will enable the buying, selling, and licensing of KlickZie pictures and videos everywhere.

Recently, Tautachrome announced that it hired the Pryor Cashman law firm in New York to lead its work to register its KLK cryptotoken sale with the Securities and Exchange Commission (SEC). Mr. Ali Panjwani with support from his colleagues Mr. Jeff Alberts and Mr. Mike Campoli is leading the Pryor Cashman work team.

This team has considerable cryptotoken knowledge. In addition, it has significant experience with SEC registration. This includes past employment with the SEC in this area.

Tautachrome Chief Executive Officer, Dr. Jon N Leonard, said, “I have directed the Pryor Cashman team to work with the SEC’s crypto currency task force to ensure that our vision for a KLK cryptotoken-based ecosystem, able to monetize the world’s smartphone imagery becomes a reality, and that it is fully compliant with SEC regulations. We appear to be breaking new ground in this work. But I believe that the social and economic potential of this effort is so great, that every effort is justified.”

Tautachrome, Inc. (TTCM), closed Monday's trading session at $0.007, up 37.2549%, on 48,832,580 volume with 466 trades. The average volume for the last 3 months is 50,892,348 and the stock's 52-week low/high is $0.0003/$0.009999999.

chart

IGEN Networks Corp. (IGEN)

NetworkNewsWire.com, MarketWatch, InvestorsHub, Marketwired, OTC Markets, Information Vine, Business Insider, Stock Press Daily, The Street, and Barchart reported on IGEN Networks Corp. (IGEN), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

IGEN Networks Corp. is a foremost innovator of cloud-based and Internet of Things (IoT) automotive solutions for the protection and management of mobile assets. The Company provides peace-of-mind to automotive consumers and their families via direct access to IoT cloud-based services, which include Stolen Vehicle Protection, Real-time updates on asset health and Driver Behavior. OTCQB-listed and incorporated in 2006, IGEN Networks has its head office in Murrieta, California.

The Company provides vehicle tracking and recovery solutions to the automotive dealership industries in the U.S. IGEN Networks serves the automobile industry through vehicle security services, lot management services, and driver behavior services.

IGEN Networks enables automotive dealer channels to provide new products, create additional revenue streams, as well as keep their customers. The Company provides peace-of-mind to consumers through providing direct access to vehicle status and driver behavior. The Company also enables insurance companies to decrease their rating errors through offering consumers discounted premiums in return for access to vehicle and driver behavior data.

This past October, IGEN Networks announced the launch of Medallion GPS™. Medallion GPS™ is a new, easily installed, direct-to-consumer solution. It combines vehicle agnostic hardware with cloud based smartphone software. This system provides automotive aftermarket customers with a new standard in stolen vehicle recovery support, vehicle systems alerts, driver behavior monitoring and GPS tracking capabilities, in addition to other features.

In November, IGEN Networks announced the filing of its Q3 2017 financial results. The Company increased year-to-date Revenue 26 percent to 1.04 million, boosted by growing adoption of its mobile asset tracking platforms. It grew the subscriber base 264 percent year-over-year, to over 31,000 assets at September 30, 2017.

IGEN increased deferred revenue 146 percent, to $182,000. The Company increased gross margin to 39.2 percent through the first nine months, versus 36.8 percent in the previous year period. It reported a Net Loss of $662,000 year-to-date, excluding stock based compensation expenses, versus $551,000 in the previous year nine-month period.

IGEN Networks Corp. (IGEN), closed Monday's trading session at $0.03875, up 26.4274%, on 76,100 volume with 12 trades. The average volume for the last 3 months is 7,688 and the stock's 52-week low/high is $0.020999999/$0.085.

chart

Lithium Corp. (LTUM)

Breaking Bulls,  OTCPicks, SmarTrend Newsletters, PickPennyStocks,   FNNO Newsletters,  AllPennyStocks, Stockpalooza,   Canadian Microcap Report, and Stockdigest Report reported previously on Lithium Corp. (LTUM), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter. 

Lithium Corp. engages in the identification, acquisition, and exploration of metals and minerals with  an emphasis on lithium mineralization on properties in Nevada.  The  Company’s   commitment  is to the exploration for energy storage related resources  across  North America,  looking  to capitalize on opportunities within the  growing  next generation  energy storage  markets.  An exploration stage mining company,  Lithium  is headquartered  in Elko, Nevada. 

The Company maintains a strategic alliance with Altura Mining. Lithium’s flagship  property is  Fish Lake Valley.  At Fish Lake Valley,  it  holds Placer claims  that cover roughly 7,800 acres.  The Fish Lake Valley Property is in northern Esmeralda County in west-central Nevada.

In  north-western Nevada, Washoe County, Lithium has its San Emidio Project. The Company  staked a block of claims in the San Emidio Valley during September of  2011, and  presently  holds 1,600 acres.

Additionally, it has its North Big Smokey lithium brine exploration property in Big Smokey Valley, Nye County, Nevada.  This property is on federal lands. It consists of 44 association placer claims,  most which are 80 acres. In total the prospect is approximately 3,400 acres.

Lithium  has its BC Sugar Property situated in Shuswap, B.C. It  has assembled a 19,816-acre (8,019 hectare) block of mineral claims in  B.C.  that is highly prospective for hosting commercially extractable deposits of flake graphite. 

Furthermore, the Company has its Hughes Property in  Tonopah, Nevada.  Lithco participated in the  establishment of Summa LLC,  a private Nevada Limited Liability company that  holds 88 fee-title patented lode claims that cover about 1,191.3 acres of prospective mineral lands.  Lithium signed a Joint Operating Agreement with the other participants to govern the conduct of Summa, and the development of the lands.

This past October,  Lithium announced that it recently excavated a ''mini bulk'' sample at its BC Sugar flake graphite prospect in B.C. This sample was submitted to SGS Lakefield's laboratory in Burnaby, B.C. 

Elsewhere in B.C, the Company has ended work on the Bormal option properties. It is now awaiting final assay results from these new Rare Earth Element/Tantalum-Niobium prospects. The results will include further assays from a zone discovered in July 2017 where initial assays indicated Total Rare Earth Element (TREE) content was up to 0.75 percent.

In December, Lithium announced that Summa LLC, which Lithium owns a 25 percent interest in, recently entered into an agreement where it will sell a 100 percent interest (subject to a ½ percent Net Smelter Royalty or NSR) in the 20-acre Copper Chief patented mineral claim in Nevada for $103,000.  Moreover, Summa received an offer to option its other four patented claims in the Goodsprings Mining District.

Lithium’s President, Mr. Tom Lewis, is a Managing Member of Summa, which holds manifold properties across Nevada, which originated from Howard Hughes’s Summa Corporation. 

Lithium Corp. (LTUM), closed Monday's trading session at $0.102, up 36.00%, on 109,781 volume with 23 trades. The average volume for the last 3 months is 61,641 and the stock's 52-week low/high is $0.050999999/$0.27000001.

chart

The QualityStocks Company Corner

Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI)

The QualityStocks Daily Newsletter would like to spotlight Organigram Holdings Inc. (OGI).

In anticipation of the legalization of adult use recreational cannabis edibles in Canada, as well as consumer demand for cannabis-infused beverages, Organigram Holdings Inc. (TSX VENTURE: OGI) (NASDAQ: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, has developed a proprietary nano-emulsification technology that will allow for the production of both liquid and powdered cannabinoid products.

Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) is the parent company of Organigram Inc., a leading Canadian licensed producer (“LP”) of high-quality cannabis and extract-based products. Founded in 2013, Organigram is focused on producing high quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to expand the Company’s global footprint. 

The Company has distribution arrangements in all 10 provinces1. Organigram delivers industry-leading yields and maximizes quality cannabis production at the lowest cultivation cost per gram among publicly reporting Canadian LPs.

Financial Results

In Q2 2019, the Company reported record net revenue of C$26.9 million, cash cost of cultivation of C$0.65 per gram, industry leading gross margin of C$16 million or 60% and adjusted EBITDA of C$13.3 million or margin of 49%, positive for the third consecutive quarter.

Significant Expansion Plans with Streamlined Licensing Process

Located in Moncton, New Brunswick, Organigram’s production facility and research & development program includes a state of the art, indoor 3-tier cultivation system which maximizes facility square footage. Its Phase 4 expansion project is expected to be completed by the end of 2019 for increased target production capacity of 113,000 kg/year (249,000 lbs)2. As the Company expands its cultivation and processing capacities, Organigram is able to file amendments to the existing facility and each new production area is largely a replica of previously licensed areas, which results in a relatively streamlined and predictable licensing process with Health Canada.

In addition to increased production capacity from Phase 4, Organigram’s Phase 5 expansion includes plans for additional extraction capacity and its own edibles facility. Construction is expected to be substantially completed in October 2019.

Proprietary Technology

The Company’s indoor facility allows for control of all critical facets of the lighting and environmental elements to drive maximum quality and yield in the plants. The Company’s in-house proprietary information technology system, called OrganiGrow, tracks grow cycles, environmental conditions and other factors to optimize cultivation.

Numerous design and automation improvements include automated potting, pre-roll and packaging machines, and larger propagation rooms with advanced environmental systems.

Well Positioned for Canada’s Legalization of Edibles and Other Derivatives Products

Through its facility expansions, partnerships and research and development, the Company is well-positioned to capture further growth from the legalization of edibles and derivative products expected in October 2019. Its initial product focus is on vaporizable products and edibles.

Organigram’s development of a shelf-stable, thermally stable, water-soluble and tasteless cannabinoid nano-emulsion formulation may provide for an initial onset of effect within 10 to 15 minutes in a beverage. Non-cannabis formulations with a similar molecule size are water-soluble in humans (i.e., absorbed through the bloodstream rather than requiring first-pass liver metabolism, which results in longer onset and duration uncertainty). The Company expects to receive research and development licensing in the near term, at which point testing will be conducted to confirm the onset and duration.

Organigram has entered into an exclusive consulting agreement with The Green Solution (TGS), a proven market leader based in Denver, Colorado for the development of commercial scale extraction and derivative product development in Canada. Organigram’s partnership with Canada’s Smartest Kitchen, a leader in food product development, will expand the Company’s edibles R&D program.

The Company recently announced a C$15 million investment commitment in a high-speed, high-capacity, fully automated production line with a capacity of 4 million kilograms of exceptional chocolate cannabis edibles per year.

Organigram also has a multiyear extraction contract with Valens GroWorks Corp. to produce extract concentrate for oils and other derivative products.

Disruptive Technology

Through its partnership with Hyasynth Biologicals Inc., a biotech company and leader in the field of cannabinoid science and biosynthesis, Organigram has invested in a potentially disruptive technology that uses patented yeast strains and enzymes to naturally produce cannabinoids without growing the cannabis plant. This process has the potential to create a global supply of pure cannabinoids at a fraction of the cost of traditional cultivation. Organigram views this investment as providing early access to what it expects to be the future of cannabinoid production – cost-effectiveness, purity and scalability.

International

Organigram believes there will be increasing demand for CBD in Canada and beyond. As such, the Company has invested in Alpha-Cannabis Germany (ACG) and expects to provide ACG with flower for conversion into extracts. ACG is a medical cannabis provider serving the largest legalized medical market in Europe. The Company anticipates entering into an agreement with ACB to purchase pure synthetic CBD isolate in the future.

Organigram is also invested in Eviana Health Corp. (CSE: EHC), a Serbian-based company with hemp farming and processing assets.

Experienced Executive Team

  • CEO Gregory Engel has 30 years of national and international experience in pharmaceuticals, biotechnology, cannabis, and consumer packaged goods (CPG), and most recently served as CEO of Tilray Inc. where he was instrumental in the company becoming the first Canadian exporter of medical cannabis, as well as establishing several trailblazing industry standards
  • Jeff Purcell, Senior Vice President of operations, has 25 years of experience in operations for companies such as Ganong Chocolates and McCain Foods
  • Tim Emberg, Senior Vice President of Sales and Commercial operations, has 20 years of experience in pharmaceutical sales and marketing in the OTC and CPG industries
  • Paolo DeLuca, Chief Financial Officer, has 20 years of diversified financial business experience including with West Face Capital and TD Securities
  • Ray Gracewood, Senior Vice President, Marketing & Communications, has 15 years of experience in the marketing space and was senior Director of Dales and Marketing for Moosehead Breweries Ltd.

This profile contains certain non-IFRS performance measures including cash and all-in cost of cultivation per gram, net revenue, adjusted EBITDA, and adjusted gross margin which are not calculated in accordance with IFRS and may not be comparable to similar data presented by other companies. Please see the company’s Q2 2019 MD&A.

1 Subject to final regulatory approval from Quebec
2 Several factors can cause actual capacity and costs to differ from estimates. See “Risks and Uncertainties” in the Company’s Q2 2019 MD&A and “Risk Factors” in the latest Annual Information Form.

Organigram Holdings Inc. (NASDAQ: OGI), closed Monday's trading session at $7.08, up 7.9268%, on 1,792,477 volume with 6,413 trades. The average volume for the last 3 months is 935,175 and the stock's 52-week low/high is $2.97000002/$8.43999958.

Recent News

chart

Pressure BioSciences Inc. (PBIO)

The QualityStocks Daily Newsletter would like to spotlight Pressure BioSciences Inc. (PBIO).

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences industry, recently announced that its patented pressure cycling technology (“PCT”) platform was featured in 15 independent scientific presentations at the annual conference of the American Society of Mass Spectrometry (“ASMS”) (http://nnw.fm/geA6Y).

Pressure BioSciences Inc. (PBIO) develops, markets and sells proprietary laboratory instrumentation and associated consumables to the life sciences sample preparation market. Sample preparation refers to the wide range of activities that precede most forms of scientific analysis. It is often complex and time-consuming, yet a critical part of scientific research. The market for sample preparation products is currently estimated at $6 billion worldwide.

The Company’s product line can be used to exquisitely control the sample preparation process. It is based on a patented, enabling technology platform called pressure cycling technology (“PCT”). PCT uses alternating cycles of hydrostatic pressure between ambient (14.5 psi) and ultra-high levels (up to 100,000 psi) to safely and reproducibly control critical biological processes, such as the lysis (breakage) of cells, the digestion of proteins, and the inactivation of pathogens.

Pressure BioSciences’ product line is led by its newly released, next-generation Barocycler 2320EXTREME instrument. Named a finalist in the prestigious 2017 R&D Awards (also known as the “Oscars of Innovation”), the Barocycler 2320EXT is already being touted by some key opinion leaders as an essential element of the $1.8 billion U.S. “Cancer Moonshot” program. For example, Professor Phil Robinson, Co-head of the cancer research center of the Children’s Medical Research Institute (Sydney, Australia), said in a recent interview: “We are collecting the whole proteome on 70,000 tumor samples from all classes where complete clinical outcome is known. Due to its unique capabilities, the Barocycler 2320EXT has become a critical part of our program. It is the primary enabler of the high-throughput component of the project. Without this step, our project simply could not be done. In fact, the Barocycler 2320EXT works so well we have just purchased two more.”

Momentum is building when it comes to the potential for using the Company’s unique PCT technology platform. Leading scientists are intrigued by Pressure BioSciences’ approach, which among other attributes, revolutionizes the process of rupturing cells (lysis) for further study, yielding superior biomolecules for investigation. The Company’s technology transcends current methods of breaking open cells, which use chemicals, blades, metal beads, or other damaging and altering methods that can ultimately adversely affect the result for researchers. Pressure BioSciences’ PCT technology utilizes customized, controlled hydrostatic (water) pressure to rupture cells in a chamber, enabling exquisitely customized levels of pressure to optimally break open different types of cells at prescribed pressure levels—something never before accomplished in a commercial setting. Using this pioneering method, the result is a truer, more legitimate sample, which boosts the efficacy of research and the quality of results. The potential impact of this technology on scientific advancement is enormous, enabling research scientists to begin their studies with biological samples of unprecedented integrity, with the potential to improve research outcomes at the earliest, most critical step. PCT can additionally inactivate pathogens (e.g., viruses, bacteria) using hydrostatic pressure, making the samples safer to study—another innovation with astronomical potential for application in a variety of markets.

The Company’s high-pressure instruments for research purposes are marketed throughout the United States, Europe, China and Japan. To date, Pressure BioSciences has installed nearly 300 PCT Systems in over 165 leading academic, government, biotech and pharma laboratories around the world. Its primary applications are in biomarker discovery, forensics, agriculture and pathology. Over 100 scientific papers have been published on the advantages of the PCT platform, which is also being used in the specialized fields of drug discovery and design, bio-therapeutics characterization, soil and plant biology, vaccine development and histology.

Impressive as their biotech business is, there is more to the PBI story. Pressure BioSciences recently received two patents in China for its novel Ultra Shear Technology (UST), a process that has potential in a wide range of industrial applications, including extending the shelf life of some food products and making two insoluble liquids (like oil in water) soluble. Patents have also been filed in many other countries worldwide. UST is a novel technique based on the use of intense shear forces generated from ultra-high-pressure valve discharge.

This important technology has the potential to play a significant role in a number of commercially important areas through its ability to create high-quality, stable nanoemulsions. Scientific studies indicate that improved absorption, higher bioavailability, greater stability, lower surfactant levels and other advantages can be achieved with nanoemulsions – all hugely important factors in the fields of nutraceuticals, cosmetics, pharmaceuticals, and in various medical products. There is an enormous opportunity in the cannabis market, since the technology can potentially reduce oil droplets containing cannabidiol (CBD) to nanoparticles, after which they can be safely suspended in a stable water solution—something many companies have endeavored to achieve without success. Researchers looking for a way to increase the bioavailability of cannabinoids in the body will find this technology a game changer.

The Company’s UST technology also has possibilities in the production of clean label foods, which are currently processed using several innovative methods, including high-pressure treatments (such as Starbucks’ Evolution line of juices). In 2015, the worldwide market for high-pressure processed (HPP) food was estimated at U.S. $10 billion. UST uses ultra-high pressures and certain valves to generate intense shear forces under controlled temperature conditions to produce nanoemulsions, and which also significantly reduces food-borne pathogens. Pressure BioSciences’ initial focus with this technology will be to evaluate UST for the production of high-quality dairy products and beverages.

Pressure BioSciences Inc. (PBIO), closed Monday's trading session at $3.45, up 0.58309%, on 6,255 volume with 21 trades. The average volume for the last 3 months is 9,185 and the stock's 52-week low/high is $1.51999998/$4.0999999.

Recent News

chart

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF)

The QualityStocks Daily Newsletter would like to spotlight Canopy Rivers Inc. (RIV) (CNPOF).

Canopy Rivers Inc. (TSXV: RIV) (OTC: CNPOF) is pleased to share that its portfolio company, James E. Wagner Cultivation Corporation ("JWC") (TSXV: JWCA) (OTCQX: JWCAF), has received approval of a licence amendment from Health Canada. This licence amendment allows for the sale of formulated cannabis oil from JWC's pilot facility in Kitchener, Ontario. In anticipation of this news, JWC is prepared to commence the sale of formulated cannabis oil to JWC's medical cannabis patients on July 9, 2019. 

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) is the venture capital investment platform of Canopy Growth Corporation (TSX:WEED, NYSE:CGC).

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers collaborates with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. Headquartered in Toronto, Canada, Canopy Rivers has developed an ecosystem of complementary cannabis operating companies operating throughout the cannabis value chain.

Canopy Rivers, in collaboration with Canopy Growth, has established a diverse portfolio of cannabis industry investments that includes domestic and international companies, licensed producers, late-stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. Investments are customized for each counterparty and include a balanced mix of equity, debt, royalty and profit-sharing agreements.

Canopy Rivers’ expanding portfolio includes:

  • Agripharm Corp. (private) is an ACMPR licensed producer, acquired by Canopy Growth in January 2017. In November 2017 Agripharm completed a joint venture with globally recognized partners Green House Seeds and Organa Brands. Canopy Growth has sublicensed proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm to distribute the suite of Green House and Organa Brands products across the country, when permissible.
  • CanapaR Corp. (private) owns 80% of CanapaR Italy, a Sicily-based company focused on developing and commercializing Italy’s local hemp cultivation industry through its partnership with the renowned Department of Agriculture at the University of Catania and its rapidly building extraction capabilities for the production of organic CBD oil. CanapaR Italy’s outsource farming model with local Sicilian farmers and its university partnership will provide it with a low-cost source of organic CBD oil, which is increasingly used as an input into new commercial products in the growing health and wellness industries.
  • Civilized Worldwide Inc. (private), is a media and lifestyle brand with offices in New Brunswick and California that embraces and highlights modern cannabis culture. Civilized aims to engage the millions of productive, motivated people who choose to enjoy cannabis responsibly as part of their lifestyle. Reaching 2+ million unique visitors per month, North America-wide, Civilized produces engaging content for and about people who enjoy cannabis responsibly.
  • James E. Wagner Cultivation Ltd. (TSXV:JWCA) was founded in 2007 by third generation agricultural and cannabis cultivators. JWC is the first entirely aeroponic producer of cannabis in Canada, and its patent-pending aeroponic production technology, called GrowthStormTM, allows for perpetual harvesting and improved yields. The company was issued a license to cultivate from Health Canada in January 2017 and a subsequent sales license in March 2018.
  • LiveWell Foods Canada Inc. (TSXV:LVWL) was established in 1993 as a nutritional lifestyle company, and operates in the production of fresh produce and food technology. The company’s O-Hemp division distributes bulk and retail hemp products through its existing channel partners. LiveWell entered into a strategic agreement with Canopy Rivers and Canopy Growth in April 2018.
  • PharmHouse (private) is a joint venture between Canopy Rivers and the principals and operators of leading North American greenhouse produce companies. PharmHouse has arranged to acquire a newly built 1.3-million-square-foot greenhouse located in Leamington, Ontario.
  • Radicle Cannabis Inc. (private) is an ACMPR-licensed cannabis company based in Hamilton, Ontario backed by a management team that brings extensive experience in regulated industries, retail distribution, tobacco and pharmaceutical development, as well as Award-winning cannabis horticulturist breeders and medical professionals.
  • Solo Growth (TSXV:ALZ) is a new cannabis retail concept that will operate locations under the name “YSS by Solo,” relying on the expertise of a management team comprised of founding shareholders, senior officers and board members of Solo Liquor Stores Ltd., a leading Canadian liquor retailer. Solo Growth was established through a recapitalization of Aldershot Resources Ltd.’s corporate structure that will allow the company to execute a new retail-focused cannabis business strategy.
  • Spot Therapeutics Inc. (private) is an applicant that was acquired by Canopy Growth in August 2017 to solidify its Maritimes expansion strategy and less than four weeks later Canopy Growth signed a supply MOU with the New Brunswick government. Canopy Rivers purchased the property and entered into a long-term lease and committed funding agreement with Canopy Growth.
  • TerrAscend Corp. (CSE:TER) cultivates high-quality cannabis in an indoor hydroponic facility, backed by a strategic investor boasting a strong background in the pharmaceutical space and an extensive portfolio of specialty pharma assets.
  • Vert Mirabel (private) is a joint venture that was established in December 2017 between Canopy Rivers, Canopy Growth, and Les Serres Stephane Bertrand. Bertrand is a large-scale greenhouse operator located in Mirabel, Quebec, and the largest grower of pink tomatoes in the country. With guidance and assistance from Canopy Growth, the greenhouse has been upgraded and retrofitted for cannabis production and was licensed by Health Canada in May 2018.

As the company’s portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves. Canopy Rivers believes this formula results in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and across the entire Rivers ecosystem.

Canopy Rivers is led by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks. The company’s acting CEO and chairman is Bruce Linton, CEO of Canopy Growth and founder of Tweed Marijuana.

Canopy Rivers Inc. (OTC: CNPOF), closed Monday's trading session at $2.63, up 10.9705%, on 319,485 volume with 733 trades. The average volume for the last 3 months is 111,326 and the stock's 52-week low/high is $1.75/$7.30155992.

Recent News

chart

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX)

The QualityStocks Daily Newsletter would like to spotlight Foresight Autonomous Holdings Ltd. (FRSX).

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX), today announced that last week the company successfully completed a series of technological demonstrations of its QuadSight vision system in the United States for five leading vehicle manufacturers (OEMs) and six Tier One suppliers. These demonstrations follow successful technological roadshows that were recently carried out in Japan and France. Demonstrations of the QuadSight™ vision system were performed in the Silicon Valley area and Detroit with the assistance and support of FLIR Systems

Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX), founded in 2015 and headquartered in Israel, is a technological innovator in automotive vision systems and driver assistance technology. Through its wholly owned subsidiary, Foresight Automotive Ltd., Foresight is engaged in the design, development and commercialization of stereo/quad-camera vision systems and V2X cellular-based solutions for the automotive industry based on 3D video analysis, advanced algorithms for image processing and sensor fusion. The company’s powerful and patented stereoscopic technology is derived from field-proven technology that has been deployed throughout the world for almost two decades.

Foresight’s innovative autonomous driving solutions are based on mature, proprietary stereoscopic image technology that uses two synchronized cameras to mimic human depth perception and produce a three-dimensional image. This 3D image can anticipate possible collisions with other vehicles, cyclists, pedestrians and other obstacles. The technology provides highly accurate real-time alerts about the vehicle’s surroundings while in motion. The systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts.

The company’s patents provide IP protection for its robust and proven proprietary stereoscopic technology, which was developed using the security technology of Foresight’s major shareholder, Magna B.S.P.

Foresight has developed three main products:

  • QuadSight™. This breakthrough detection system sets the bar for autonomous vehicle vision. It features nearly 100 percent obstacle detection with almost zero false alerts and operates optimally under all weather and lighting conditions, including darkness, rain, fog, haze and glare. QuadSight™ is the first quad-camera multi-spectral vision solution of its kind, driven by advanced and proven image processing algorithms. The system consists of two sets of stereoscopic infra-red and visible-light cameras that enable highly accurate and reliable obstacle detection for seamless 24/7 vision.
  • Eyes-On™. This solution uses advanced algorithms for accurate depth analysis and obstacle detection to provide a unique stereo vision Advanced Driver Assistance System (ADAS). It can detect all potential obstacles regardless of shape, form or material, including other vehicles, cyclists, pedestrians and animals. It has an accuracy and reliability of almost 100 percent and near zero false alerts.
  • Eye-Net™. This is a cellular-based accident prevention solution that is designed to provide real-time pre-collision alerts to vehicles and pedestrians. This proprietary system is deployed on smartphones and cloud-based servers operating on existing cellular networks, and it eliminates the need for additional designated hardware. Eye-Net™ is designed to provide a complementary layer of protection to advanced driver assistance systems and extends this protection to road users who are not in direct line of sight. It is optimally designed for both urban environments and high-speed scenarios to provide protection for the most vulnerable road users. On March 28, 2018, Foresight announced that it had completed a successful feasibility study of its Eye-Net™ accident prevention solution involving 120 users of Android and iOS cell phones located across Israel.

In 2017, Foresight sought more opportunities within the international market. The Company signed pilot agreements with three leading car manufacturers in China and completed pilot projects meeting all pre-defined requirements and criteria. In addition, FRSX completed a pilot project with Uniti Sweden.

Studies by the Insurance Institute for Highway Safety continue to emphasize the dramatic reduction in accidents and injury-related crashes reported when vehicles are equipped with collision avoidance systems. A recent study by the Institute states that the rate of single-vehicle, sideswipe and head-on crashes was 11 percent lower in vehicles with the warning systems. More importantly, the study shows collision avoidance technology cut the rates of injury crashes of the same type by 21 percent.

Foresight Autonomous Holdings, Inc. also holds a 32 percent interest in RailVision, a company that develops advanced systems for railway safety and maintenance. RailVision has successfully completed 13 tests in Israel, Germany, Italy and Switzerland in addition to a real-time system test with a European railway operator. Over the course of 2017, RailVision successfully completed rounds of financing totaling $5.8 million and started the process of licensing the system according to European standards.

Haim Siboni is the founder of Foresight and has served as the company’s chief executive officer and director since 2015. Siboni, a passionate entrepreneur, has an extensive background in the marketing and business management sectors in the fields of electronics, video, TV, multimedia, computerized systems, line and wireless telecommunication, design and development of systems and devices, including electro-optic radar systems. He is the founder and CEO of Magna B.S.P., Foresight’s major shareholder and a leading innovator in the field of homeland security surveillance solutions.

Foresight Autonomous Holdings Ltd. (FRSX), closed Monday's trading session at $1.88, up 3.2967%, on 519,347 volume with 1,196 trades. The average volume for the last 3 months is 455,904 and the stock's 52-week low/high is $0.697000026/$3.45000004.

Recent News

chart

Trxade Group Inc. (TRXD)

The QualityStocks Daily Newsletter would like to spotlight Trxade Group Inc. (TRXD).

The proprietors of America’s independent pharmacies may well be cheering as the S2P (supplier to pharmacy) trading platform pioneered by Trxade Group Inc. (OTCQB: TRXD) swings into full gear, for its benefits extend to both trade and customers. The web-based platform not only identifies the best available prices for prescription drugs – a boon to patients – but helps pharmacists avoid negative reimbursement costs, which reduce profit margins.

Trxade Group Inc. (TRXD) is an integrated pharmaceutical services company that offers a unique combination of a web-based purchasing platform (www.trxade.com) for transactions between independent pharmacists and drug distributors (B2B); a network of pharmacies with E-Hub software; a mail order pharmacy; and warehouse and drug delivery services. This synergistic combination of product offerings and superior data analytics is poised to benefit all stakeholders and consumers within the pharmaceutical industry.

Trxade will leverage and scale its fully integrated model to execute the following growth strategies:

  • Increase share of pharmacist drug purchasing
  • Additional SKUs and expand product breath
  • Partner with Specialty and International Mfg.
  • Expand mail order licenses to all 50 states
  • Scale Delivmeds for consumer delivery nationwide
  • Integration with telemedicine
  • M&A Opportunities within drug value chain

Founded in 2010 and headquartered in Tampa, Florida, Trxade's overarching corporate strategy is to penetrate the existing retail independent pharmacy marketplace and diversify the company's pharmaceutical mix with additional specialty and acute care products. Trxade is advancing on this mission by focusing on three key niches in the health care market.

Business-to-Business (B2B)

The $330 billion U.S. pharmaceutical industry is comprised of more than 65,000 pharmacy facilities and 1,500 state-licensed suppliers. Roughly 24,000 of these facilities are independent pharmacies, which collectively spend approximately $93 billion a year on branded and generic drugs.

Trxade targets these independent pharmacies, leveraging a robust, "E-Bay/Kayak-like" technology platform with optimum buyer/seller pricing algorithms, product availability, and predictive data analytics features.

Trxade currently serves and transacts with more than one-third (10,250) of these independent pharmacies and facilitates over $10 million of drug purchases a month!

Consumer

Trxade also targets the "consumer side" of the pharmaceutical industry, aiming to lower prescription drug costs by attacking the inefficient value chain; offering drug price transparency and efficient buying; and, delivering drugs DIRECT to independent pharmacists and consumers.

The company operates a full-service mail order pharmacy for U.S. consumers, as well as a mobile app called "Delivmeds" (http://www.delivmeds.com) which enables SAME DAY home delivery of dispensed prescriptions.

Retail

Trxade's Managed Services Organization ("TrxadeMSO") enables its member independent retail pharmacies to get patients, process orders, and deliver or ship prescriptions to patients. TrxadeMSO provides access to encompassing network of pharmacies through the E-Hub software, allowing for timely and comprehensive medication fulfillment.

These offerings ensure the best-suited pharmacy receives the patient's information, thereby ensuring appropriate medication coverage based on the patient's location, payor coverage, and medication access/inventory. This will save the clinicians and their staff time as they benefit from efficiency and enhanced workflow management in script processing and fulfillment.

Health Care Market

The U.S. health care market currently hovers near $4 trillion and is expected to grow as the general population ages. This growth will have greater impact on consumers as out-of-pocket expenses also rise. Additionally, drug costs are paced to increase faster than the overall health care and well above inflation.

Drug pricing is variable, and reimbursement is squeezing profits. This provides significant opportunity for the Trxade model of price visibility and profit optimization.

Trxade's fair online market platform targets the nation's retail community and independent pharmacies, of which there are approximately 24,000 nationwide. TRxADE has found that independent pharmacies, in order to be cost-effective, often operate with minimal staff and conduct up-to-the minute price checks. The TRxADE S2P platform gives these pharmacists the ability to easily compare the price of drugs offered by various suppliers and select the most favorable deals, saving money by taking advantage of best purchase pricing.

TRxADE's programs include:

  • TRxADE Exchange, which opens and widens the distribution channel to the retail, community pharmacy. A purchasing pharmacy can view products from manufacturers, buying groups, and wholesalers on a real-time and continuous basis. This approach significantly enhances the competitive spirit of the exchange where the lowest price exists for each product at any given point in time. TRxADE has become a competitive tool for all progressive entities and is recognized for its easy searching of hard-to-find generic pharmaceuticals at substantially reduced prices.
  • RX Guru™ is an industry-leading price prediction model that integrates product shortage insight into pharmacy acquisition benchmarks ("PAC") to ascertain trends and pricing variances that result in significant purchasing opportunities. RX Guru affords members the opportunity to continuously benefit from real price purchasing opportunities that are concealed from the rest of the industry.
  • Product Shortage Database – TRxADE maintains the most comprehensive retail, specialty and acute care pharmaceutical product shortage database in the country. Other industry competitors mainly restrict their efforts to specialty and acute care product shortages and narrowly research oral generic products. TRxADE's advanced prediction tools help members source those hard-to-find products at affordable costs in a timely and easy-to-search process.

Management Team

Trxade's management team is rich in expertise within the pharmaceutical supply chain and is supported by a base of advisors and contractors who are experts in related fields of the pharmaceutical sector.

Suren Ajjarapu – Chairman of the Board, Chief Executive Officer and Secretary

Suren Ajjarapu has served as Trxade's chairman of the board, CEO and secretary since 2014, and as the chairman of the board, chief executive officer and secretary of Trxade Nevada since its inception. Ajjarapu also serves as a chairman of the board for Feeder Creek Group Inc., since March 2018. Ajjarapu formerly was a founder, CEO and chairman of Sansur Renewable Energy Inc., a company involved in developing wind power sites in the Midwest, United States; a founder, president and director of Aemetis Inc., a biofuels company (AMTX.OB); a founder, chairman and CEO of International Biofuels, a subsidiary of Aemetis Inc.; and a co-founder, COO, and director at Global Information Technology Inc., an IT outsourcing and systems design company. Ajjarapu holds an M.S. in environmental engineering from South Dakota State University, Brookings, South Dakota, and an MBA from the University of South Florida, specializing in international finance and management. Ajjarapu is also a graduate of the Venture Capital and Private Equity program at Harvard University.

Prashant Patel – Director, President and Chief Operating Officer

Prashant Patel has served as Trxade's full-time president and COO, and as a director since the company's acquisition of Trxade Nevada in 2014, and as the COO and president and as a director of Trxade Nevada since its inception. He has been a president and member of the board of Trxade since August 2010. Patel is a registered pharmacist and pharmaceutical consultant with over 10 years of experience in retail pharmacy and pharmaceutical logistics. He is the founder of several pharmacies in the Tampa Bay area, in Florida. Since 2008, Patel has been managing member of the APAA LLC pharmacy. Since 2007, Patel has been a vice president of Holiday Pharmacy Inc. Patel graduated from Nottingham University School of Pharmacy and practiced in the United Kingdom before obtaining his masters in Transport, Trade and Finance from Cass Business School, City University, UK.

Trxade Group Inc. (TRXD), closed Monday's trading session at $0.63, up 5.00%, on 1,300 volume with 1 trade. The average volume for the last 3 months is 3,929 and the stock's 52-week low/high is $0.230000004/$0.75.

Recent News

chart

Endonovo Therapeutics Inc. (ENDV)

The QualityStocks Daily Newsletter would like to spotlight Endonovo Therapeutics Inc. (ENDV).

Endonovo Therapeutics Inc. (OTCQB: ENDV) is transforming the field of medicine by developing safe, wearable, non-invasive bioelectric medical devices that deliver Endonovo’s Electroceutical™ Therapy. Targeting inflammatory conditions in vital organs and peripheral tissues, Endonovo’s SofPulse® is clinically proven to significantly speed the recovery process and reduce the need for potentially addictive pain medications, thereby improving the patient’s natural recovery experience (http://nnw.fm/O9UUp).

Endonovo Therapeutics Inc. (ENDV) develops, manufactures and distributes evolutionary medical devices focused on the rapid healing of wounds and reduction of pain, edema and inflammation on and in the human body. These wearable, non-invasive medical devices are designed to deliver the company’s proprietary, patent protected Electroceutical™ Therapy targeting inflammation, cardiovascular diseases, chronic kidney disease and central nervous system (“CNS”) disorders.

In accord with its mission to transform the field of medicine through innovation, Endonovo’s bioelectric Electroceutical™ devices harness bioelectricity to restore key electrochemical processes that initiate anti-inflammatory processes and growth factors in the body necessary for healing to rapidly occur. Endonovo’s current portfolio of commercial-stage devices address chronic kidney disease, liver disease non-alcoholic steatohepatitis (NASH), cardiovascular and peripheral artery disease (PAD), and ischemic stroke.

Flagship Therapy

SofPulse® Electroceutical ™ Therapy is an easy-to-place, non-invasive device that delivers pulsed electromagnetic frequencies to enhance post-surgical recovery. Used as a stand-alone therapy or integrated into any treatment protocol, SofPulse®’s?targeted?pulsed electromagnetic field?(tPEMF)?transmits gentle pulses to the tissue causing a positive biological effect to help reduce swelling and accelerate the body’s natural recovery process. The low levels of electromagnetic fields are completely safe and are 1000 times lower than those emitted by a mobile phone.?

Because SofPulse® lessens the pain of post-surgical recovery, the patient requires far less prescription medications, thereby minimizing or eliminating the adverse side effects of narcotics and anti-inflammatory medication. Studies have shown a greater than 2.2-fold reduction in narcotic use over the first 48 hours post-procedure. Patients with less pain and medication may move around sooner, which further stimulates the body’s natural response to healing.

Certifications

Endonovo’s Electroceutical™ Therapy is cleared by the U.S. Federal Drug Administration (“FDA”) for the palliative treatment of pain and post-surgical edema (swelling) and is CE-marked in the European Economic Area (“EEA”) for the promotion of wound healing and the palliative treatment of pain and post-surgical edema. The Centers for Medicare and Medicaid Services (“CMS”) has also certified Electroceutical™ Therapy for the treatment of chronic wounds.

Management

Alan Collier, Chairman and CEO
Alan Collier has more than 25 years of experience in corporate finance, IP development, telecommunications and technology, with a concentration in healthcare and technology over the past five years. Collier has served as CEO and director of IP Resources International Inc., where he was instrumental in developing a platform the for the licensing and acquisition of life science and technology companies. He has held numerous board and executive positions throughout his career in the telecommunications, technology, specialty finance, corporate finance and healthcare industries. Collier has previously held FINRA Series 7, 79, 63 and 24 licenses.

Michael Scott Mann, President
Michael Scott Mann has over 30 years of experience in merger and acquisitions and operational management. In 2008, Mann acquired the assets of Hanover Asset Management, now Endonovo Therapeutics Inc., and led the company to become listed on the OTCBB in 2012. He was the founder, president and CEO of Frankfurt-listed U.S. Debt Settlement Inc. (USDS), where he implemented a growth by acquisition strategy.?

Don Calabria, Chief Operating Officer
Don Calabria has over 20 years of leadership and experience in national business operations to emerging growth companies, mergers and acquisitions, finance and business development. Calabria holds an MBA from the Graziadio School of Business and Management at Pepperdine University and a bachelor’s degree from Arizona State University.

Nevena Zubcevik, Chief Medical Officer
Nevena Zubcevik, D.O., MSPT, ATC, on July 1, 2019, will lead Endonovo’s medical and clinical strategy, including the development and regulatory matters and new business development. Zubcevik, a licensed physician and educator, has more than 24 years of experience in the medical field and was an attending physician at Harvard Medical School/Partners Healthcare in the physical medicine and rehabilitation department.

Steven Ford, Vice President of Marketing
Steven Ford has 25 years of experience in the field of medical devices, including experience in sales management, product management, product development, business development and research & development at companies such as Baxter, CR Bard, Ethicon, Allergan, Mallinckrodt Pharmaceuticals and Alphatec Spine. Throughout Ford’s career, he has led and participated on over 75 product development teams and has launched over 50 medical devices globally. Ford is an innovative problem solver and has many patents in the areas of hemostasis, sealing and tissue reconstruction. Most recently, Steve was the U.S. vice president of marketing for Biom’up where he was a co-lead on the high-profile successful launch of their surgical hemostat HEMOBLAST Bellows. Steve holds a bachelor’s degree in marketing from California State University.

David Clark, Vice President of Sales
David Clark has extensive surgical device commercial experience which includes 25 years in the surgical device industry with leading companies including Medtronic and Baxter Healthcare. Most recently, Clark was the U.S. executive vice president of sales for Biom’up where he was a co-lead in the high-profile successful launch of their surgical hemostat HEMOBLAST. As part of the launch, he built and led the U.S. sales team which included over 200 in-direct sales representatives and direct commercial leadership. During his 15 years with Baxter, the BioSurgery Division grew from a small revenue business into a major market player in the advanced hemostasis space with products such as FloSeal and Tisseel. Clark has a bachelor’s degree in economics from Rutgers University.

Roc Alan McCarthy, Scientific Advisory Board Member
Roc Alan McCarthy, D.O, will help Endonovo continue to advance its clinical pipeline and contribute to the strategic and clinical development oversight of the company. McCarthy is a urologist in North Carolina, currently serving as the robotic surgeon and chairman of the robotics committee at the New Hanover Regional Medical Center.

Endonovo Therapeutics Inc. (ENDV), closed Monday's trading session at $0.0183, up 4.5714%, on 2,555,090 volume with 69 trades. The average volume for the last 3 months is 5,313,857 and the stock's 52-week low/high is $0.008999999/$0.066100001.

Recent News

chart

Sharing Services Global Corporation (SHRG)

The QualityStocks Daily Newsletter would like to spotlight Sharing Services Global Corporation (SHRG).

Sharing Services Global Corporation (OTCQB: SHRG) is focusing on international expansion, initially by growing into the Canadian direct-selling market, which was estimated at $2.6 billion in 2017 by the Direct Sellers Association of Canada (DSA) and at $3 billion in 2019 by Ibis World (http://nnw.fm/2dMuo). SHRG is also proceeding with its application for uplisting to the Nasdaq Capital Market (http://nnw.fm/d3Y9O). Also today, NetworkNewsWire released a report on the company detailing how SHRG employs a home-based business entrepreneurship model through its Elepreneur network of independent sales associates. To view the full article, visit: http://nnw.fm/8o0Yi

Sharing Services Global Corporation (SHRG), headquartered in Plano, Texas, is a diversified holdings company focused on reshaping how entrepreneurs succeed today. Sharing Services Inc. owns, operates or controls an interest in a variety of companies specializing in the direct selling industry that either sell products to the consumer directly through independent representatives or offer services that range from health and wellness, energy, technology, insurance services, training, media and travel benefits. SHRG has created the “Blue Ocean Strategy,” which melds three keys together to implement the company’s vision. These keys include elevating home-based entrepreneurs, known as “Elepreneurs,” utilizing the direct selling channel to generate 100 percent organic growth.

Sharing Services Inc. subsidiaries include:

  • A growing international network of home-based entrepreneurs, called “Elepreneurs”
  • Growing selection of health and wellness products dedicated to elevating the well-being of all people
  • Insurance from auto, home and life to health benefit discounts and health insurance that help families elevate their options
  • Wholesale travel and payment programs with travel concierges that empower more families to go on vacation
  • Live seminars and training events – from Vacationars™ to EduTainment – that elevate the skills and knowledge of entrepreneurs around the world
  • Unique compensation and reward programs crafted to help entrepreneurs elevate their health, wealth and happiness

Sharing Services recently expanded its corporate footprint by moving to a 10,000 square foot facility in Plano, Texas, that offers room to expand as the company grows and its subsidiaries flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.

“The opportunity to expand to the rest of this new building over the course of the next six to 12 months ensures we won’t have to move again anytime soon,” Sharing Services Inc. Chairman Robert Oblon said. “We are on track for very significant growth here in the U.S., as well as upcoming international expansion, so this move is in preparation for what’s in front of us.”

The company recently signed a joint venture agreement with Health Wealth & Happiness Limited (“HWH”) to expand its “Elepreneurs” brand and market its products throughout Asia. The newly formed company will be named “Elepreneurs Asia Limited” and will have marketing and sales rights to China, Hong Kong, Macau, South Korea, Japan, Taiwan, Cambodia, Indonesia, Laos, Malaysia, the Philippines, Singapore, Thailand, Vietnam and Papua, New Guinea. A soft launch of the Elepreneur program is scheduled sometime later in 2018 with HWH CEP Fai Chan and his team leading the effort. Formed in Hong Kong, Health Wealth & Happiness Limited is dedicated to working with visionary partners like Sharing Services Inc. to deliver the best products and services to improve the well-being of consumers.

Nearly 1,000 people attended Sharing Services Global Corporation ’s first “Elepreneur Happiness Convention,” held March 2-3, 2018, in Dallas, Texas. Attendees arrived from several countries including the U.S., Canada, Mexico, Singapore and Hong Kong. Keynote speakers included several internationally known motivational leaders – Shawn Achor, Sandra Yancey, John Fleming and Les Brown – who provided exceptional material and inspirational discussion points.

“The enthusiasm of our attendees and the early success that we are experiencing is incredible considering our growth has been 100 percent organic, with almost no marketing from the company,” Oblon said. “I’m speechless by the dedication of our Elepreneur leaders and their entire teams, as they share our incredible line of products that have helped so many people.”

Sharing Services and its management team plan to travel the U.S. to hold several mini conferences to expand on the messages presented at its Happiness Convention that focus on helping people become “healthier, happier and wealthier.” Details of the company’s aggressive global expansion initiatives are soon to be announced, Oblon said.

The law firm of Gardere Wynne Sewell LLP has been retained as outside corporate counsel for all general business matters. The Dallas-based law firm will represent Sharing Services Global Corporation , and its subsidiaries as the company utilizes the direct selling channel for a significant component of its overall growth strategy.

John “JT” Thatchwas appointed president and chief executive officer of Sharing Services Global Corporation , at a March 1, 2018, annual shareholder meeting. Thatch has successfully started, owned and operated several sized businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist Sharing Services Inc. as the company aims to expand and increase revenues.

Sharing Services Global Corporation (SHRG), closed Monday's trading session at $0.1897, even for the day, on 16,110 volume. The average volume for the last 3 months is 19,976 and the stock's 52-week low/high is $0.1026/$0.3944.

Recent News

chart

TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8)

The QualityStocks Daily Newsletter would like to spotlight TransCanna Holdings Inc. (CSE: TCAN).

TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) this morning announced its entry into a definitive acquisition agreement dated July 6, 2019, to acquire The Goodfellas Group LLC, a company specializing in branding, sales and marketing in the cannabis and hemp industries. To view the full press release, visit http://nnw.fm/Ah8eb.

TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8) brings together a rapidly growing portfolio of cannabis and hemp-related brands and services, with a closed-loop ecosystem approach rooted squarely in the company’s ownership of a 196,000-square-foot, vertically integrated facility in California. The company has developed a two-year, four-phase plan aimed at developing proprietary brands and creating a self-contained ecosystem that ensures reliability, consistency, quality and scale.

Ecosystem

TransCanna’s cannabis facility in Modesto, California, is strategically located less than a three-hour drive from the majority of all major cities in the state. The tri-level building provides internal control of everything needed for the seed-to-sale cycle, from growing and manufacturing to extraction, bottling, transportation and distribution. The facility, which recently went through an US$8 million renovation, is upgraded with a premium quality HVAC system and highly insulated roof to help reduce power costs, which already are some of the lowest in California.

The company has set 2020 goal for implementation of its full-service software platform, 420 Global, which will interact with every aspect of production flow, business development and the sales process.

Growing Portfolio

Acquisitions slated to be completed in June include Goodfellas Group LLC, a full-service advertising and marketing agency for the U.S. cannabis and hemp industries. Under the deal, TransCanna will also be acquiring Daily Cannabis Goods, a pre-rolled brand with nominal start-up costs and superior SKU velocity with cannabis products available at more than 30 dispensaries throughout California.

On Deck

The company has moved to acquire organic hemp-infused CBD coconut oil Biovelle (www.Biovelle.com). Biovelle is non-GMO, vegan and gluten free, with coconut sourced from plantations in the Philippines and American grown hemp from farms in Colorado.

TransCanna has also moved to further secure a growing foothold in cannabis edibles via a non-binding letter of intent with Persuasion Brewing Co., located near the company’s flagship facility in Modesto. The goal is to establish a Persuasion Brewing division at the main facility, which will produce a variety of different CBD infusion non-alcoholic beers.

Similarly, the company has recently executed a non-binding LOI with SolDaze (Tres Ojos Naturals, LLC) to gobble up the branding asset package of this California manufacturer of cannabis-infused fruit snacks (www.soldazesnacks.com).

Management

TransCanna’s management team consists of seasoned agriculture and consumer goods-oriented veterans.

Director, CEO and Chairman James Pakulis has 30 years of experience working with public and private entrepreneurial companies in a variety of emerging sectors. He has been on the front lines of the California cannabis industry for nearly a decade. He was CEO and chairman in 2010 of General Cannabis, Inc., which wholly owned the popular Weedmaps brand. Pakulis oversaw the growth of General Cannabis from pre-embryonic stages to over $16 million in revenue in less than two years, reaching a market cap of approximately $480 million.

Director and President Arni Johannson brings over 30 years of investing experience in the Canadian capital markets. He has built and or funded over 50 startups from around the world. He is president of Canadian Nexus Ventures and has been instrumental in providing guidance to pre- and post IPO companies, as well as guidance and oversight for corporate governance.

Stephen Giblin, board director, is an accomplished leader in the global hospitality, technology and real estate industries with a demonstrated track record of value creation. Juan Pablo Flores, independent director, is an attorney with more than 25 years of legal experience with a strong background in municipal, government, real estate, corporate and general civil law litigation.

The company’s strategic advisors include individuals with extensive experience in branding, marketing, sales, distribution, production and supply chain management.

TransCanna Holdings Inc. (CSE: TCAN), closed Monday's trading session at $2.80, off by 11.95%, on 750,713 volume with 726 trades. The average volume for the last 3 months is 137,267 and the stock's 52-week low/high is $0.76999998/$7.78999996.

Recent News

chart

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)

The QualityStocks Daily Newsletter would like to spotlight The Green Organic Dutchman (OTC: TGODF).

The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a cannabis-focused research and development company, is on a mission to establish itself as an international leader in delivering premium organic cannabis solutions. To view the full article, visit: http://nnw.fm/9OVyy.

The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).

Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.

TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.

Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.

Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.

The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.

The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.

TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.

Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.

Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.

TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.

To learn more about the company and how to invest, contact TGOD directly at financing@tgod.ca

The Green Organic Dutchman (OTC: TGODF), closed Monday's trading session at $2.5379, off by 0.863281%, on 339,328 volume with 598 trades. The average volume for the last 3 months is 597,782 and the stock's 52-week low/high is $1.60699999/$7.89379978.

Recent News

chart

Geyser Brands Inc. (TSX.V: GYSR)

The QualityStocks Daily Newsletter would like to spotlight Geyser Brands Inc. (TSX.V: GYSR).

Geyser Brands Inc. (TSXV: GYSR), a Health Canada-approved Licensed Producer based in Vancouver, BC, has found a solution to this problem with its ground-breaking developments in nanotechnology, dubbed NanoFusion, which breaks down cannabinoid particles and combines them with naturally-occurring surfactants which lower the surface tension between cannabinoids and water, resulting in a compound that is water compatible. Also today, the company was featured in the 420 with CNW by CannabisNewsWire. The exploding popularity of CBD as a health and wellness product in a largely unregulated market (so far) creates a need for each buyer to vigilant when deciding where to spend their hard-earned money on CBD products.

Geyser Brands Inc. (TSX.V: GYSR) is a consumer healthcare company that builds and markets some of the world's most loved cannabis products and brands in the nutraceutical, cosmetics, food and beverage and pet sectors. Using its proprietary nanotechnology formulation, the company delivers creams, beverages, baked goods and tincture formulations with superior bioavailability and water solubility.

NanoFusion Technology

The efficacy of most hemp?products is restricted as the insoluble nature of the molecules prevents most of the product from permeating the skin or entering the body system. Geyser Brands solves this insolubility problem with an advanced delivery system that quickly and efficiently transports therapeutic agents directly to the bloodstream for maximum absorbency.

Made with all-natural materials, NanoFusion technology offers an array of advantages: enhances penetration for deeper skin penetration; improves the transport of active ingredients for site-specific targeting; delivers active ingredients across cell membranes for release within the cell; provides longer shelf-life and stability of molecules.

Operations

Geyser Brands operates a 7,000-square-foot facility in Port Coquitlam, British Columbia, where its initial cannabis cultivation generated the first revenues out of the company's cultivation license granted in October 2018. Geyser Brands is approved as a licensed producer in compliance with Health Canada standards, which allows the company to pursue its processing and sales license. Obtaining this license will enable the company to extend its products and brands into the regulated Canadian cannabis market and directly to the consumer medical market.

Geyser Brands's integrated production chain and formulation lab develops innovative products using high-quality hemp and CBD for healthy lifestyle brands while its R&D lab produces product formulations designed to enhance bio-availability of hemp and CBD and shelf stability while maintaining all-natural ingredients and ensuring premium quality.

Geyser Brands will continue to seek opportunities to invest into the research and development of unique high-quality proprietary strains and technologies that target specific health-related conditions such as pain and inflammation reduction, insomnia, digestive issues and other commonly known ailments.

Growing Portfolio

Among the brand formulations in Geyser Brand's portfolio are:

  • Apothecary all-natural Hemp Terpene Pain Cream with optimal skin permeation
  • Prohibition Cold Brew Mocha designed with water soluble hemp molecules
  • Apothecary health products created to deliver fast-acting and high bioavailability in a spray formulation
  • Baked hemp infused pet products, designed to alleviate anxiety and pain, created with NanoFusion for dosage control

Management Team

Since 2014, Geyser Brands' CEO and Co-Founder Andreas Thatcher has been a principal at Rhizome Group, an entertainment company focused on building media IP through creative and market development. He previously was a founding partner at Rhizome Capital LLC, a U.S.-based media?investment?company specializing in marketing and distribution financing, and worked in the Investment Banking industry in?London and Toronto. Thatcher holds a master's degree in economics.

CFO Barry McKnight obtained his bachelor's degree from the University of British Columbia and is a Chartered Professional Accountant and?Certified Management Accountant registered in British Columbia. McKnight has over 20 years of experience as the principal of Barry D. McKnight Inc. He formerly was also a director of Indigo Sky Capital Corp. and has been the CFO and a director of the Company since 2016 and Corporate?Secretary of the Company since 2017.

Geyser Brands's Co-Founder Brad Kersch brings a strong business background with over 20 years of experience in?successful startups and working?with Fortune 500 companies. He spent his early years in the advertising and?marketing field and went on to form Hyperware, a clothing?company that sold branded clothing to retailers across Canada?before selling to clothing giant Ocean Pacific (OP). Kersch?became the president of Shoreline Studios, Canada's largest and?oldest?studio for film and TV. In 2014 he started Solace Management Group, a hemp product company focused on pet, cosmeceutical, and nutraceutical markets. As of February 2019, Geyser Brands signed a non-binding LOI to acquire Solace Management. Upon completing the proposed Solace acquisition, Geyser Brands intends to launch into the execution phase of its plan — to take its brands global through retail and digital direct-to-consumer experiences, launching its hemp-infused cannabis brands and products in the U.S., European Union, and Asia, and its CBD-infused line of products in jurisdictions where the therapeutic ingredient is legal.

Kuldip Gill, head of Geyser Brands' R&D program, has more than 35 years of experience in the cannabis industry. Gill built the largest manufacturing facility?in the lower mainland in Surrey, British Columbia, complete with R&D, analytical and quality control labs approved by both the FDA and Health Canada. He has to date created over 3,500 formulas, most notably Lakota pain relief gel. Gill's experience and proven track record is evident in the strongly marketable formulations he has developed and sold worldwide.

Geyser Brands Inc. (TSX.V: GYSR), closed Monday's trading session at $0.55, off by 1.79%, on 2,000 volume with 3 trades. The average volume for the last 3 months is 8,497 and the stock's 52-week low/high is $0.33/$0.85.

Recent News

chart

Nightfood Holdings, Inc. (OTCQB: NGTF)

The QualityStocks Daily Newsletter would like to spotlight Nightfood Holdings, Inc. (NGTF).

Nightfood, Inc. (OTCQB: NGTF), the fast-growing ice cream company solving America’s $50 billion-dollar nighttime snacking problem, is excited to announce its second celebrity custom flavor in a partnership with NFL superstar Richard Sherman. Sherman stars for the San Francisco 49ers and is a graduate of Stanford known for his big heart and love of the spotlight. Entering the 9th year of his NFL career, he has made 4 NFL Pro-Bowls and 4 All-Pro Teams and earned the singular honor of being featured on the cover of the iconic EA Sports Madden video game while a member of the Super Bowl Champion Seattle Seahawks in 2015.

Nightfood Holdings, Inc. (OTCQB: NGTF), a pioneering consumer goods brand development company headquartered in Tarrytown, New York, owns Nightfood, Inc., creator of delicious, award-winning and better-for-you ice cream formulated by sleep and nutrition experts, and its wholly owned subsidiary MJ Munchies, Inc., which seeks to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. Known as “The Nighttime Snack Company,” Nightfood Inc. is focused on improving the late-night snacking choices of consumers while solving America’s $50 billion-dollar nighttime snacking problem.

Nightfood Ice Cream

Nightfood’s higher-protein and sleep-friendly ice cream won the 2019 Product of the Year Award in a survey of over 40,000 consumers. The annual Product of the Year survey, the world’s largest consumer-voted award for product innovation, is conducted by Kantar, a global leader in consumer research. In beating out the other finalists, consumers indicated that Nightfood’s one-of-a-kind innovation and unique value proposition made it a clear-cut winner in the ice cream space and a brand they were highly motivated to try. Winners of the 32-year-old award have been shown to outperform category sales performance by over 38 percent.

Less than two months since manufacturing their first pint of ice cream, Nightfood has now secured distribution in more than 13 states, and has received extensive media coverage from outlets such as USA Today, Fox Business’ Mornings With Maria, Parents Magazine, The Food Network, MarketWatch, The Washington Post, Business Insider, Bustle, and more.

With the Product of the Year award and millions in media coverage, Management has publicly stated their goal of securing nationwide distribution in over 10,000 retail outlets by March 31, 2020.

Formulated by leading sleep and nutrition experts, including America’s most prominent sleep expert, Dr. Michael Breus, Nightfood’s higher protein/higher fiber, and lower sugar ice cream delivers great ice cream taste and texture, while minimizing sleep-disruptive ingredients such as caffeine, excess sugar, and excess fat and calories. The addition of certain minerals, enzymes and amino acids, which research suggests can support sleep quality, is another bonus. Nightfood only uses hormone-free milk, is certified Kosher, and offers eight original flavors, five of which are gluten-free. Nightfood ice cream also uses all-natural sweeteners with no Erythritol, no sucralose, or other artificial sweeteners.

More than 37,000 consumers across the country have already requested coupons for the company’s newly launched Nightfood ice cream by entering a giveaway hosted at NightfoodIceCream.com which includes a chance to win a one-year supply (96 pints) plus a freezer for storage. The coupon program is being run in conjunction with PromotionPod, which has previously conducted successful campaigns for brands such as Chobani, Halo Top, and BodyArmor.

Nightfood Inc. began its nationwide rollout of Nightfood ice cream in February 2019, successfully securing placement in Meijer supermarket locations in the Midwest with a concentration around the metropolitan areas of Chicago, Detroit, Indianapolis, Columbus and Milwaukee. A distribution agreement with New England Ice Cream Corporation (NEIC) will also place Nightfood ice cream in outlets located throughout Massachusetts, Vermont, New Hampshire, Maine, Rhode Island and Connecticut.

Ice cream lovers in northern California will find Nightfood Ice Cream at various upscale, independent retail outlets in and around the San Francisco bay area serviced through a distribution agreement with Wonder Ice Cream Company, which services thousands of retail outlets from Bakersfield north to the Oregon border. Consumers can also purchase Nightfood ice cream online at BuyNightfood.com through the Company’s partnership with IceCreamSource.com.

Ice cream is now the 2nd most popular night snack choice, with almost half of all consumers reaching for ice cream after dark. According to IRI Worldwide, 44 percent of all snack consumption occurs between dinner and bedtime, representing a consumer spend of over $1 billion weekly on nighttime snacks in the U.S. alone. Market research giant Mintel recently released a report identifying nighttime specific food and beverages as one of their most “compelling and category changing” trends for 2017 and beyond.

Nightfood has developed a dynamic infographic resource that clearly illustrates the size and scope of the largely untapped nighttime snack category (http://NightSnacking.com). Americans everywhere are likely to identify with the infographic’s results that vividly illustrate late night snacking by age group, popular snack choice, and amount of money spent each week on feeding after-hour snack attacks. Available in eight delicious flavors, Nightfood ice cream can help consumers satisfy nighttime cravings in a better, healthier, more sleep-friendly way.

MJ Munchies, Inc.

MJ Munchies, Inc., was formed in 2018 as a new, wholly owned subsidiary of Nightfood Holdings, Inc. to capitalize on legally compliant opportunities in the CBD and marijuana edibles and related spaces. The Company intends to market some of these new products under the trademarked brand name “Half-Baked” and has entered into a Letter of Intent that allows Global Consortium Inc. (OTC: GCGX) subsidiary Infused Edibles to receive an exclusive license to manufacture and distribute marijuana and CBD-infused products under the Half-Baked brand.

Management believes the Half-Baked brand will give the Company a unique and defensible competitive advantage against other recreational edible brands. The Company believes tremendous opportunities currently exist to launch successful and legally compliant products in this space, and that such opportunities will continue to grow over time.

Management Team

Nightfood founder and CEO Sean Folkson is a formerly frustrated nighttime snacker whose late-night cravings led him to seek a better solution for himself and others through the creation, marketing and distribution of the Nightfood product line. Folkson also founded internet marketing company AffiliatePros.com which provided the startup capital to launch Specialty Equipment Direct, an online distributor of floor removal equipment that quickly grew to 7-figure revenues. Folkson received a bachelor’s degree in business administration with a concentration in marketing from S.U.N.Y Albany, New York, in 1991.

Jim Christensen, vice president of Nightfood Ice Cream, is the former Vice President of Ice Cream Sales with global ice cream giant Unilever. In his over 20 years at Unilever, Jim led sales and distribution initiatives for brands such as Ben & Jerry’s, Klondike, Breyers and Good Humor. Christensen joined the Nightfood team in June of 2018 with the directive to launch Nightfood ice cream rapidly into national distribution through supermarket, drug, convenience and other channels. Understanding that the overwhelming majority of at-home ice cream consumption occurs in the hours before bed, Christensen has identified Nightfood as the next evolution in better-for-you ice cream.

CFO Mark Noffke, CPA, has over 37 years of experience as a seasoned financial and management professional. He has served as chief financial officer of several small cap public companies since 2004 where he oversaw virtually every aspect of the company’s operations, administration, customer service and human resources. Noffke has a bachelor’s degree in accounting from Valparaiso University in Indiana.

Advisory Board

The Nightfood advisory board includes Tom Morse, founder of 5-Hour Energy and Living Essentials, LLC.; Doron Stern, former vice president of marketing at Chobani and Popcorn, Indiana; restaurateur and celebrity Chef Chris Santos; Paul Jarrett, CEO of fast-growing nutrition startup BuluBox; Eric Egeland, president of Capacity Consulting Inc.; Dr. Michael A. Grandner, director/Sleep and Health Research Program at the University of Arizona; Dr. Michael Breus, sleep expert and best-selling author known to millions as The Sleep Doctor(TM); Dr. Lauren Broch, resident nutrition, sleep disorder expert and a member of the scientific advisory board.

Nightfood Holdings, Inc. (NGTF), closed Monday's trading session at $0.47, off by 0.843882%, on 100,715 volume with 66 trades. The average volume for the last 3 months is 216,212 and the stock's 52-week low/high is $0.160099998/$0.920000016.

Recent News

chart

Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF)

The QualityStocks Daily Newsletter would like to spotlight Petroteq Energy Inc. (PQEFF).

Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) is demonstrating the true potential value of the Clean Oil Recovery Technology (CORT) that it has developed for surface tar sands oil extraction in Utah’s rural eastern desert. The company announced July 2 that it has entered into a non-exclusive technology licensing agreement with eastern Texas energy services company Valkor LLC, marking the first in what Petroteq hopes will become a series of licensing agreements for its technology (http://nnw.fm/zw4JE).

Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) is a Canadian-registered, publicly traded company engaged in the development and implementation of proprietary technologies for the environmentally safe extraction of heavy oils from oil sands, oil shale deposits and shallow oil deposits. The company is focused on oil sands exploration and production on mineral leases in Vernal, Utah, and in expanding production capacity at its Asphalt Ridge heavy oil extraction facility in Utah.

Petroteq Energy’s patent-pending application is a closed-loop, solvent-based process, which results in significantly lower per-barrel production costs than those incurred with traditional hot water-based oil sands extraction technologies. This green technology utilizes a small, modular footprint, produces no greenhouse gases, requires no high temperatures, leaves only clean dry sand, and could be deployed to unlock heavy oil deposits located around the world.

The Company’s Asphalt Ridge mineral lease on 2,500-plus acres in northeastern Utah features a large contingent oil sands resource base with an estimated 87 million barrels of oil equivalent. In 2015, the company produced 10,000 barrels of oil from the Utah location and plans to increase production are underway. Utah holds over 32 billion barrels of undeveloped oil sands resources, which are also known as “oil-wet” deposits containing a mixture of sand and a dense, extremely viscous form of petroleum referred to as bitumen or tar. A recent upswing in developing domestic energy sources has intensified interest in technological advances such as Petroteq’s Clean Oil Recovery Technology (CORT) System.

The Company continues to evaluate the development of other medium to heavy oil exploration, production and recovery projects on a global basis through a variety of structured agreements. These opportunities or other arrangements with private and governmental entities that utilize Petroteq Energy’s proprietary licensed technologies are expected to generate a significant return on investment.

The Company’s management team, board of directors and officers form an invaluable cross-section of industry leaders with extensive experience ranging from chemical engineering and solvent research, business development, international project management, entrepreneurial achievements, and senior management for global energy companies in North America and the Middle East. This impressive knowledge base covers both conventional and unconventional oil and gas projects and production, both in upstream and downstream industry sectors.

Petroteq Energy is also participating in a blockchain initiative aimed at solving the global transaction needs of the oil and gas industry through the development of PetroBLOQ. PetroBLOQ recently joined the Enterprise Ethereum Alliance (“EEA”), the world’s largest open-source blockchain initiative. Membership with the 200-member EEA represents a wide variety of industries and offers 14 industry-focused, member-driven working groups.

“Joining this community of forward-looking enterprises and blockchain innovators is an important step for PetroBLOQ as we develop transformative solutions for the oil and gas industry,” said Petroteq Energy Chairman Alex Blyumkin.

In addition, Petroteq has joined the American Petroleum Institute (API). The API is the only national trade association representing all facets of the oil and natural gas industry, promoting safety across the industry globally and influencing public policy in support of a strong, viable oil and natural gas industry.

“API has led the development of operating standards for our industry, and we look forward to contributing our experience with oilfield technologies in addition to introducing our PetroBLOQ platform to its members throughout the supply chain,” Blyumkin previously stated.

Petroteq Energy Inc. (PQEFF), closed Monday's trading session at $0.223063, off by 14.2065%, on 227,876 volume with 76 trades. The average volume for the last 3 months is 256,177 and the stock's 52-week low/high is $0.207000002/$1.42999994.

Recent News

chart

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

Direct Solar, a subsidiary of SinglePoint (OTCQB: SING), is pleased to announce the company has signed on to become the exclusive solar marketing partner to support the various fall sports programs for 47 Texas Schools across Dallas/Fort Worth, Houston, Austin and Waco.  Between August 1st and December 31st, 2019, any solar systems that are sold within these school districts will receive a $250 donation to the Fall Sports Booster Program at the school.

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed Monday's trading session at $0.015455, off by 3.4062%, on 6,721,367 volume with 180 trades. The average volume for the last 3 months is 5,884,345 and the stock's 52-week low/high is $0.009999999/$0.0447.

Recent News

chart

Golden Developing Solutions, Inc. (DVLP)

The QualityStocks Daily Newsletter would like to spotlight Golden Developing Solutions, Inc. (DVLP).

Emerging leader in the cannabis, hemp and CBD marketplaces Golden Developing Solutions Inc. (OTC: DVLP) today officially announced that its Form 10 registration statement, which was filed with the U.S. Securities and Exchange Commission, is effective as of July 1, 2019. To view the full press release, visit http://nnw.fm/SncM7. Also today, the company was featured in the 420 with CNW by CannabisNewsWire. The exploding popularity of CBD as a health and wellness product in a largely unregulated market (so far) creates a need for each buyer to vigilant when deciding where to spend their hard-earned money on CBD products.

Golden Developing Solutions, Inc. (DVLP), an emerging leader in ancillary software and the cannabidiol (CBD) products marketplace, provides business services and/or products supporting the cannabis industry including an online retail business for CBD, hemp oil and health/wellness related products.

Global acceptance of cannabis and related CBD products continues to increase as North America advances toward favorable legislation. Canada legalized recreational cannabis in October 2018, and the United States has 30 states and the District of Columbia allowing either recreational or medical cannabis, or both. Voters in four additional U.S. states will consider marijuana initiatives on the November 2018 ballot. The global legal cannabis market is projected to reach USD$146 billion by the end of 2025, with a greater acceptance of medical cannabis products as a driving factor, according to Grand View Research.

DVLP is taking advantage of consumer demand for CBD products through its wholly owned Pura Vida Vitamins, LLC subsidiary, which recently launched a direct-to-consumer website (www.PuraVidaVitamins.com) and commenced sales of Pura Vida branded products. Pura Vida merchandise includes hemp and CBD-related products and other products focusing on health and lifestyle which are available through established wholesale and distribution channels. In addition, a line of CBD pet supplements and other products are in development.

DVLP recently acquired “Where’s Weed” (Layer Six Media LLC DBA “Where’s Weed”) and its primary asset, WheresWeed.com. Where’s Weed is an American cannabis technology company known for connecting medical and recreational cannabis users with trusted local marijuana businesses in their communities. As a rapidly growing community-based online resource for cannabis consumers with a host of user-friendly services, Where’s Weed offers a sophisticated mobile app with strong traction and powerful growth potential as the North American legal cannabis market continues to expand exponentially.

WheresWeed.com has a large and expanding reach with nearly 3 million pageviews per month. In addition, the WheresWeed mobile app, available in both iOS and Android, has been downloaded over 80,000 times, proving to be complementary to DVLP’s objective to capitalize on the massive growth curve in the marijuana space.

“The huge flood of new growers and producers is likely to create oversupply in the near term, narrowing margins for major producers,” says DVLP CEO Stavros Triant. “However, this should actually increase the net number of new consumers in the marketplace, further reinforcing the enormous growth potential for hub service providers in the space that are situated on high-traffic internet real estate, which is exactly how we view the Where’s Weed property.”

The company’s move into the lucrative C-store snack market was solidified with a material purchase order for CBD oils from a major distributor specializing in the snack foods and accessories to the convenience store and gas station market. The order represents significant progress as DVLP gears up its ready-made snack distribution strategy for its CBD products.

“We are extremely excited about the launch of our CBD product line with this distributor,” Triant states. “The C-Store strategy dovetails perfectly with our direct marketing strategy through our primary online retail channel, and we have indications from the distributor that, if this initial test order goes well, successive Purchase Orders could be significant and underpin strong sales growth in Q1 2019.”

Golden Developing Solutions, Inc. (DVLP), closed Monday's trading session at $0.0131, off by 10.8844%, on 977,128 volume with 39 trades. The average volume for the last 3 months is 1,548,191 and the stock's 52-week low/high is $0.012199999/$0.14.

Recent News

chart

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.